HLTH Forward Podcast

In this episode, I sit down with Heather, an artist who has spent over a decade at the intersection of biotechnology, surveillance, and identity. What began as a quiet moment in a therapy session — staring at a strand of hair caught in cracked glass — became a decade-long investigation into what our discarded DNA reveals about us. Heather collects cigarette butts, chewed gum, hair, and nail clippings from public spaces, extracts the DNA, and uses it to reconstruct 3D-printed portraits of complete strangers — people who never consented to being seen, never knew they left something behind, and never imagined they'd end up on a gallery wall. I found this conversation deeply philosophical, and it made me rethink something I'd never considered: that every step we take, every cup of coffee we leave behind, we are quietly shedding a biological story that anyone — artist, scientist, or law enforcement — could one day pick up and read.But for the HLTHForward audience, this goes far beyond art. The same DNA that can reconstruct a face holds a map to our health — our ancestry, our inherited risks, and the diseases that may one day find us before we ever see them coming. Heather also opened my eyes to something that I think we all take for granted: every consent form we sign at a doctor's visit, every biopsy, every blood draw — that data lives on, changes hands, and we rarely ask where it goes. This conversation with Heather is about art, yes, but it's really about identity, privacy, and what it means to truly know yourself — and others — at the most fundamental biological level. It's one of those episodes that will change how you move through the world.AboutHeather Dewey-Hagborg is an information artist and biohacker whose work lives at the uneasy edge of science, surveillance, and what it means to be seen. Born in Philadelphia in 1982 and based in Brooklyn, New York, she is best known for Stranger Visions — a series of hyper-realistic 3D-printed portraits constructed entirely from DNA recovered from discarded objects: a cigarette butt on a subway grate, a strand of hair on a park bench, a piece of chewing gum left on the sidewalk. From those fragments, she extracted genetic data, determined traits like gender, ethnicity, and facial structure, and used face-generating software and a 3D printer to bring a stranger's face to life — without ever meeting them.Her work is as provocative as it is precise. Equal parts artist and scientist, Dewey-Hagborg doesn't just make art — she asks questions the rest of us haven't thought to ask yet: Who owns the DNA you leave behind? What does your biology say about you without your permission? And what happens when the same technology that reconstructs a face can also predict a disease? With no clear legal precedent governing what she does, her practice sits in a space that is simultaneously legal, deeply intimate, and quietly radical — forcing us to reckon with how much of ourselves we unknowingly give away every single day.Support the show

Every time a friend mentions her annual checkup, the conversation sounds less like healthcare and more like a horror story. Stirrups. A speculum. A procedure that hasn't meaningfully changed in 150 years — a tool designed before women could vote, still showing up in exam rooms like it owns the place.So when I sat down with Kara Egan, CEO and co-founder of Teal Health, I came in with real questions.Here's the number that stopped me cold: 4,200 women die from cervical cancer every year in the United States. Not because we lack the science. We have the vaccine. We have decades of research. And yet 1 in 3 women are behind on their screenings — and it's getting worse.The barriers aren't medical. They're logistical.Kara didn't set out to build a medical device company. She came up through health tech investing, had a baby, and realized it was genuinely easier to order a coffee than schedule a doctor's appointment. She met her co-founder, who had built the first prototype of the Teal Wand at Stanford Biodesign. Covid hit. Telehealth exploded. She saw the opening.What Teal built is an at-home HPV self-collection kit — a small wand, used privately, on your own schedule. Mail the sample. Get your results. No stirrups. No six-month wait.FDA authorized in May 2025. Nationwide by January 2026.Nearly half of Teal's customers were behind on screenings. Almost 20% had never been screened at all — not because they didn't care, but because the system was never designed for them.And starting January 1st, 2027, federal guidelines require it to be covered with zero cost-sharing for anyone with insurance. No copay. No deductible. Effectively free.Mark it.AboutKara Egan is the CEO and co-founder of Teal Health, the company behind the first FDA-authorized at-home cervical cancer screening kit in the United States. Named to TIME's Best Inventions of 2025, she has spent her career at the intersection of healthcare and technology — as a health tech investor, software investor, and operator at companies like Zendesk. A Stanford and Wharton alumna, Kara co-founded Teal in 2020 after recognizing that women's healthcare was long overdue for a redesign. In May 2025, the FDA authorized the Teal Wand, and by January 2026, it was available in all 50 states. She is on a mission to eliminate cervical cancer — a disease that is almost entirely preventable — by making screening accessible to every woman, everywhere.Support the show

Sitting down with Oliver, the CEO of Oath Surgical, felt less like conducting a typical healthcare interview and more like getting a front-row seat to how the future of surgery might be built. As someone whose career spans clinical surgery, medical technology, venture investing, and surgical innovation, Oliver brings a rare perspective to the conversation. Early in his career he trained as a physician in the UK, with surgical rotations in orthopedics, ENT, and colorectal surgery. However, he soon realized that his real calling was not just practicing surgery but shaping how surgical care evolves. His time working with companies like Intuitive Surgical and investing in early-stage healthcare technologies exposed him to the broader structural challenges of surgical care and convinced him that incremental improvements to the existing system would never be enough.One of the most striking insights Oliver shared during our conversation was the scale of the problem in the current healthcare system. Surgery is one of the largest cost drivers in healthcare, representing more than $1 trillion in annual spending in the United States alone. Yet a significant portion of surgical procedures that are performed in hospitals today could safely be done in outpatient surgical centers. According to Oliver, moving appropriate surgeries into outpatient environments can reduce costs by 50% to 80% while maintaining or even improving patient outcomes. This realization became the foundation of what Oath Surgical is building: a next-generation model for delivering complex surgical care in a more efficient, technology-enabled environment.At its core, Oath Surgical is creating a national network of premium outpatient surgical centers that are co-owned and operated with high-performing surgeons. The philosophy behind the model is straightforward but powerful—surgeons should lead the system, technology should support it, and the entire structure should be aligned around delivering measurable value. Instead of simply operating facilities, the company is building a digitally integrated surgical platform that connects surgeons, facilities, and patients through a unified operating system. This allows Oath Surgical to focus on three critical dimensions simultaneously: better outcomes for patients, improved experiences for surgeons, and lower overall costs for the healthcare system.A particularly fascinating aspect of our conversation centered on how Oath Surgical approaches data and artificial intelligence. Rather than layering software tools on top of existing hospital infrastructure, Oliver explained that the company is rebuilding the entire system from the ground up. Their platform integrates data from multiple sources across the entire surgical journey, including clinical records, operational workflows, patient-reported outcomes, inventory and financial systems, and even ambient data from surgical videos and sensors. By structuring this data across the full care episode, the platform creates a longitudinal view of surgical performance and patient recovery that traditional hospital systems rarely achieve.This integrated data architecture enables a wide range of AI-driven capabilities designed to reduce administrative burden and improve efficiency. Tasks that often consume hours of clinician time—such as documentation, scheduling, referrals, and coding—can increasingly be automated. Oliver described this vision as moving toward “zero documentation workflows,” where surgeons and clinical teams spend less time interacting with computers and more time focusing on patient care. In this model, artificial intelligence operates quietly in the background, handling operational complexity while leaving clinical decision-making firmly in the hands of medical professionals.Despite the growing role of AI in healthcare, Oliver was very clear thSupport the show

In this episode of HLTH Forward, I sit down with Steve Beard for a candid conversation about one of the most urgent issues in healthcare today—the people who deliver care, and the system that is pushing many of them to the brink. Across the United States, the numbers tell a powerful story: about 43% of physicians report experiencing symptoms of burnout, and nearly two-thirds of nurses—around 65%—say they are experiencing high levels of burnout. The pressure is enormous, and the cost is not only personal—it’s systemic, with burnout estimated to cost the U.S. healthcare system about $4.6 billion each year due to turnover and reduced clinical hours.  76% of clinicians say staffing shortages are preventing them from delivering high-quality care Stress reduction ranks as clinicians' second-highest workplace priority — just behind adequate staffing itselfDespite relatively high job satisfaction, 15% of physicians and 13% of nurses say they're likely to leave the profession within the next yearAs I talk with Steve, we explore what these numbers really mean for the future of healthcare. Behind every statistic is a physician working late to finish electronic records, a nurse covering extra shifts because a unit is short-staffed, or a clinician questioning how long they can keep up the pace. Research shows physicians are over 80% more likely to experience burnout than workers in other professions, and many say the growing administrative burden and regulatory complexity are major contributors.  These realities are exactly why conversations about workforce sustainability, training, and support systems are no longer optional—they are essential.In my conversation with Steve, we talked about how leadership, communication, and collaboration across healthcare ecosystems can help address these pressures and ultimately build a more resilient workforce. Because if healthcare is at a turning point, the real question isn’t just how we got here—it’s how leaders, organizations, and communities come together to shape what comes next.AboutCovista (formerly Adtalem Global Education) is a major U.S. healthcare educator, serving over 97,000 students through five accredited institutions—including Chamberlain University and Walden University—focused on closing workforce gaps. The company emphasizes tech-enabled education, AI-driven innovation, and directly connecting graduates to healthcare systemsSupport the show

In this HLTH Forward episode, I sit down with Dr. Kenneth Savin, Chief Scientist at Redwire and one of TIME100 Health’s Most Influential People of 2025, to explore how space is transforming the future of medicine.With over two decades in the pharmaceutical industry and a career that spans Eli Lilly, NASA collaborations, and the International Space Station, Dr. Savin is pioneering breakthroughs that were once science fiction. From bioprinting the first human knee meniscus and living cardiac tissue in microgravity to advancing next-generation drug development through protein crystallization in space, his work is redefining what’s possible for human health on Earth.We dive into how microgravity accelerates biomedical innovation, why space-based research could unlock new treatments for heart disease, bone loss, and neurological conditions, and what it really takes to turn space science into real-world therapies. Dr. Savin also shares his journey from pharmaceutical R&D to leading cutting-edge space biotech—and what excites him most about the future of health.This conversation is a must-listen for anyone curious about the intersection of space, science, and medicine, and how breakthroughs orbiting Earth may soon change lives everywhere.Support the show

In my conversation with Joanna Strober, CEO of Midi Health, a recentl Times 100 Health awardee, we explored the current landscape of menopause care — a space where millions of women experience significant symptoms yet remain underserved by traditional healthcare systems. Despite hormone therapy being one of the most effective treatments for menopause symptoms such as hot flashes, mood swings, sleep disturbances, and fatigue, usage rates remain strikingly low; recent research shows that fewer than 4% of women aged 45–59 use hormone therapy, even though up to 80% of women are affected by symptoms at some point in midlife. Compounding this care gap is a broader systemic challenge: only about one in five obstetricians/gynecologists and even fewer primary care physicians receive formal training in menopause management, leaving many women without knowledgeable clinicians to guide them through this critical life stage. Meanwhile, perimenopause — when hormone levels surge and crash unpredictably — can begin years before the final period and trigger mood fluctuations, physical changes, brain fog, and anxiety, underscoring the emotional and physiological complexity of this transition.Against this backdrop, Midi Health has emerged as a provider platform designed specifically to support women’s menopause journeys with personalized, evidence-based care that meets patients where they are. Launched to close the care gap that traditional healthcare has long ignored, Midi leverages a nationwide telehealth model with clinicians trained in midlife women’s health protocols, offering both hormonal and non-hormonal treatment plans that are often covered by insurance. With tens of thousands of patients served and ambitious plans to scale to care for more than a million women per year, the company is striving to transform how women experience midlife health — from dismissive, fragmented care to proactive, supportive treatment that acknowledges both the physical and emotional effects of menopause at scaleSupport the show

In this HLTH Forward episode, I spoke with Fidel Strub, and I felt the kind of strength and hope that transforms pain into power. He isn’t just a survivor — he is living proof that with knowledge, compassion, and action, tragedy can become a force for change. According to the World Health Organization, Noma — the devastating, gangrenous disease that ravages the mouths and faces of malnourished children — once afflicted an estimated 140,000 individuals per year globally, with a case-fatality rate as high as 90%. Survivors often endure severe disfigurement, lifelong difficulties eating, speaking, or breathing, and face social isolation — yet many never receive timely treatment, because far too many healthcare workers don’t recognize Noma early enough. Fidel shared that surviving Noma gave him a “second chance at life.” But survival alone wasn’t enough — dignity, acceptance, and opportunity were what truly mattered. As a co-founder of the survivor-led advocacy group Elysium, he and his fellow survivors turned personal trauma into a public mission. Their campaign helped ensure that in 2023, Noma was finally added to the WHO’s official list of neglected tropical diseases. This milestone opens the door to funding, research, education, and treatment.Now he champions early detection, basic antibiotic treatment, and reconstructive surgery — but most of all, he fights for the right of survivors to be seen as people deserving of dignity, not pity.And Noma is far from an isolated tragedy. Across the globe, millions suffer from rare diseases — deeply misunderstood, under diagnosed, and grossly under-resourced. Experts estimate there are more than 7,000 rare diseases worldwide, affecting up to 3.5–5.9% of the global population — that’s hundreds of millions of people.  Many begin in childhood: around 70 % of rare diseases are genetic, and a significant proportion manifest before adulthood. Yet over 95% of these conditions lack an approved treatment, reflecting a shocking disparity between need and support. At its core, Fidel’s story — and the broader rare-disease crisis — challenges us to expand our vision of healthcare and humanity. It’s not just about surviving illnesses; it’s about ensuring dignity, inclusion, and opportunity for every human being, regardless of where they were born or how rare their condition. Support the show

In this episode, featuring Dr. Eric Nestler, offers a fascinating glimpse into the intersection of neuroscience, addiction, and depression. Dr. Nestler explains that both conditions share similar brain mechanisms, particularly within the limbic system, which regulates emotion and motivation. His laboratory’s research delves into how chronic stress or drug exposure alters molecular pathways in these emotional brain regions, leading to maladaptive behaviors. Through advanced techniques like transcriptomics, his team analyzes thousands of brain molecules simultaneously, helping to uncover key differences between healthy and diseased brains. This cutting-edge work not only enhances our understanding of mental health disorders but also opens new possibilities for targeted treatments and resilience-building therapies.Beyond the science, Dr. Nestler highlights broader social and ethical dimensions. He emphasizes that the global rise in addiction and depression reflects modern societal stressors—social isolation, technological pressures, and post-pandemic effects. While innovative approaches like AI-driven analysis and brain–computer interfaces show promise, he cautions that such technologies must be pursued with great ethical care. Ultimately, his message centers on balance: advancing research while nurturing everyday resilience through healthy living, social connection, and emotional awareness. His closing insight—that true health comes from integrating science, empathy, and humanity—resonates as both hopeful and urgent for the future of healthcare.AboutDr. Eric J. Nestler, MD, PhD, is a leading neuroscientist and physician renowned for his groundbreaking research on the molecular and epigenetic mechanisms underlying depression and drug addiction. Currently serving as the Interim Dean of the Icahn School of Medicine at Mount Sinai and Chief Scientific Officer of the Mount Sinai Health System, Dr. Nestler has played a transformative role in advancing brain science through his leadership of the Friedman Brain Institute and his own laboratory’s work. His research has shed light on how chronic stress and repeated drug exposure alter gene expression and neural circuits, particularly through discoveries such as the transcription factor ΔFosB, a key regulator of long-term changes in the brain’s reward pathways. Dr. Nestler earned his BA, MD, and PhD from Yale University and has held prominent academic positions at Yale, UT Southwestern Medical Center, and Mount Sinai. He is an elected member of the National Academy of Sciences, the National Academy of Medicine, and the American Academy of Arts and Sciences, and has published hundreds of influential scientific papers. Deeply committed to diversity in science, Dr. Nestler is also known for promoting inclusive leadership and mentorship throughout his career.Support the show

In this episode, Mario Schlosser, Founder & Chief Technology Officer at Oscar Health, emphasized his belief that the future of health insurance lies in decentralization, with providers taking on more responsibility for the role that insurers have traditionally played. He argued that insurance companies, as they currently exist, act as unnecessary middlemen that add limited value to the system. Instead, Schlosser envisions a model where caregivers evolve to function like insurers, combining payment and care delivery into a unified structure. He highlighted how Oscar Health’s technology-first infrastructure is designed not just for its own members but as a platform that providers could adopt, helping them manage care and financial risk more seamlessly. This integrated approach, he believes, would create a more efficient system that better aligns incentives to improve outcomes while reducing costsAt the same time, Schlosser was clear that Oscar Health’s guiding mission is centered on the Affordable Care Act (ACA) marketplace, which he described as the company’s “north star.” With millions of Americans relying on ACA plans, he sees this market as the proving ground for new models of consumer-focused, technology-enabled coverage. By focusing exclusively on the ACA  in the 18 states it serves, Oscar is doubling down on serving individuals directly, ensuring affordability, better navigation, and improved health outcomes. Schlosser tied this vision to a broader hope: that U.S. healthcare will evolve toward an individualized system where people can stay with the insurance and care model they trust for the long term, making the ACA both a foundation and a catalyst for the transformation he wants to see.BIOMario Schlosser is the Co-Founder & Chief Technology Officer at Oscar Health. In this role, Mario leads product and engineering, with a focus on building Oscar’s technology platform for the future and continuing to set the strategy for +Oscar.Previously, Mario served as CEO of Oscar, leading the company from inception to serving over 1M members. Before co-founding Oscar, Mario also co-founded the largest social gaming company in Latin America, where he led the company's analytics and game design practices. Prior to that, Mario was a Senior Investment Associate at Bridgewater Associates and worked as a consultant for McKinsey & Company in Europe, the U.S. and Brazil.Mario also spent time as a visiting scholar at Stanford University, where he wrote and co-authored 10 computer science publications, including one of the most-cited computer science papers published in the past decade, in which he developed the EigenTrust Algorithm to securely compute trust in randomized networks. In May 2019, Mario and his co-authors, Sepandar D. Kamvar (Mosaic Building Group Inc) and Héctor Garcia-Molina (Celo), received the prestigious Seoul Test of Time Award from the International World Wide Web Conference Committee (IW3C2) for this work.Mario holds a degree in computer science with highest distinction from the University of Hannover in Germany and an MBA from Harvard Business School.Support the show

In this episode, I sit down with Kate Musler, Chief Financial Officer of Highmark Health Plan, to talk about the incredibly complex puzzle of modern healthcare—where affordability, access, and quality must all coexist. Kate walks us through her path into the field and what has kept her here: the challenge of finding real solutions in a system that impacts every one of us. We dig into the pressures of rising costs, the tough negotiations between payers and providers, and how Highmark approaches these conversations with patients at the center. Kate highlights the financial balancing act she oversees: keeping the organization stable and sustainable while ensuring people get the care they need when they need it. It’s a candid, eye-opening look at what it means to manage health insurance in a world where even small changes have massive ripple effects.We also dive into the shift toward value-based care, where providers are paid for outcomes instead of volume. Kate explains why this model is essential—not just for reducing unnecessary treatments and lowering costs, but for building healthier communities over the long term. But as she points out, transitioning to VBC isn’t easy; it requires visionary leadership, true partnership between payers and providers, and the financial flexibility to support those changes without sacrificing quality. We explore how technology, community programs, and reinvestment strategies are helping bridge the gap between financial responsibility and compassionate care. And through it all, Kate shares her hope that collaboration, transparency, and innovation will move healthcare toward a future where both patients and providers can thrive.AboutIn March 2025, Kate Musler was promoted to the C-suite of Highmark Health Plan, the health insurance arm of Highmark Health. In this role, Kate is responsible for providing strategic financial leadership for the Highmark Health Plan. She is responsible for developing, implementing, and maintaining targeted efforts to ensure the economic stability and viability of the Highmark Health Plan, including the transformation necessary to operate as a successful integrated delivery and financing system.She first joined Highmark in 2019 as senior vice president of underwriting and swiftly moved up the ranks. During her tenure at Highmark, Kate has overseen various functions and ensured the financial stability of the health plan. In her previous role, she oversaw actuarial, underwriting, and provider network functions covering 7 million members. She was also responsible for efforts to create an advance payment program following the Change Healthcare cybersecurity breach that rocked the sector in 2024. Her areas of expertise include underwriting, actuarial services, medical cost analysis, networking contracting and operations, and regulatory advocacy.Support the show

In my recent discussion with Christina Lopes, founder of FidoCure and fellow Young Global Leader, we examined a troubling but under-discussed reality: cancer incidence in companion animals is rising sharply. The trend mirrors human oncology—rooted in extended lifespans, environmental exposures, and improved detection—and raises critical questions for both veterinary and human medicine.The epidemiological data are compelling:1 in 4 dogs will develop neoplasia during their lifetime.Nearly 50% of dogs over 10 years old receive a cancer diagnosis.An estimated 6 million canine cancer cases are identified annually in the U.S.Breed-specific predisposition is pronounced; purebred dogs are almost twice as likely as mixed breeds to develop certain cancers, with high-risk breeds showing onset as early as 5–7 years, compared to a median of 9 years in mixed breeds.Christina’s work at FidoCure is predicated on a big-data, precision-medicine model for veterinary oncology. By aggregating and analyzing genomic, clinical, and longitudinal health data from thousands of dogs, her team is building predictive algorithms capable of identifying at-risk individuals before symptomatic disease emerges. The vision is a transparent, owner-facing platform—one that transforms the “four-legged life course” into a navigable, data-informed journey that prioritizes prevention over reaction.From a translational science perspective, this work has profound implications. Comparative oncology—the study of naturally occurring cancers in animals to inform human health—benefits enormously from canine genomic data. Recent research underscores the potential:The largest canine tumor sequencing study to date (671 dogs, across over 20 tumor types) identified dozens of mutation hotspots that parallel human oncogenic drivers.Comparative genomic analyses have demonstrated high concordance in mutations such as TP53, PIK3CA, and BRAF, opening the door for cross-species therapeutic strategies.Clinical trials in dogs using targeted therapies (originally developed for humans) have yielded response patterns that closely predict human outcomes—accelerating drug validation timelines.Christina’s mission exemplifies a systems-level approach: build robust datasets in veterinary health, leverage machine learning to forecast disease risk, and allow those insights to cycle back into both animal and human oncology. In our conversation, it became clear that advancing predictive and preventive medicine in dogs is not a niche pursuit—it is an accelerant for innovation in global cancer care.AboutChristina Lopes is the CEO and co-founder of FidoCure, a platform that utilises artificial intelligence and genomic sequencing to deliver personalised treatments for pet dogs with cancer, while also accelerating the development of lifesaving cancer therapies for humans. Under her leadership, FidoCure has expanded to over 1,350 veterinary clinics worldwide and has treated nearly 6,000 dogs afflicted with cancer.In collaboration with the AI Health leadership at Stanford University, Christina has developed the world’s largest and most comprehensive canine cancer dataset, comprising over two billion data points collected from patients in real-world clinical settings. She has co-authored peer-reviewed research published in leading scientific journals, including Nature Precision Oncology. Support the show

In this episode, I sit down with Dr. Edgar Engleman, a pioneering Pathologist and physician-scientist at Stanford University whose work has shaped the very foundation of cancer immunotherapy. As we face rising global cancer rates, Dr. Engleman shares his insights into the evolving landscape of cancer research and what the numbers really mean—scientifically and socially.We dive deep into his groundbreaking research on erythropoietin (EPO) and its surprising implications in cancer biology, as well as his continued innovations in using the immune system to fight tumors. Dr. Engleman also opens up about his involvement with vee-vo Capital and offers candid thoughts on the role of venture capital in bridging science and real-world impact.No conversation about the future of medicine is complete without exploring AI. Dr. Engleman shares his perspective on how artificial intelligence is beginning to transform cancer detection and prediction, and how it might reshape diagnostics, treatment decisions, and even drug development.But what strikes me most is Dr. Engleman’s enduring optimism—rooted in decades of scientific rigor. Despite the challenges, he remains steadfast in his belief that with a science-backed, collaborative approach, curing cancer is not just a dream—it’s a destination. This episode is a masterclass in science, hope, and what it means to pursue truth in medicine.AboutDr. Edgar G. Engleman, MD, PhD, is a renowned pathologist and physician-scientist who serves as Professor of Pathology and of Medicine (Immunology & Rheumatology) at Stanford University School of Medicine. He received his BA magna cum laude from Harvard in 1967 and his MD from Columbia University in 1971. Following postdoctoral training in biochemistry at the NIH and immunogenetics at Stanford, he joined the Stanford faculty in 1978 and earned tenure in 1990. Dr. Engleman founded the Stanford Blood Center in 1980 and continues to serve as its Medical Director. He also co-directs the Tumor Immunology & Immunotherapy Program at the Stanford Cancer Institute and is affiliated with several interdisciplinary research centers, including Bio-X, the Diabetes Research Center, and the Neurosciences Institute.Dr. Engleman’s research has made pioneering contributions to the field of cancer immunotherapy. His laboratory was the first to isolate and engineer dendritic cells to stimulate anti-tumor immune responses, work that led to the development of Sipuleucel-T (Provenge), the first FDA-approved active immunotherapy for cancer. His recent work focuses on reprogramming tumor-associated myeloid cells to trigger T-cell responses against cancer, with these approaches now in clinical trials. Beyond oncology, his research explores immune mechanisms in metabolic diseases, neurodegeneration, and transplantation, influencing innovative strategies like radiation-based tolerance induction. Dr. Engleman has mentored over 150 trainees, published more than 300 scientific papers, and teaches a popular course on tumor immunology at Stanford.Support the show

In this compelling episode, I sit down with Matteo Franceschetti, the Italian-born Co-Founder and CEO of Eight Sleep, to explore how his journey from competitive ski racing to legal practice to clean-tech entrepreneurship led him to revolutionize the $500 million sleep optimization industry. Franceschetti shares his unique perspective on performance optimization, drawing powerful parallels between the recovery routines of elite athletes and the overlooked sleep needs of frontline healthcare workers. His company’s AI-powered platform is pushing boundaries by shifting the conversation from generic sleep hygiene to hyper-personalized, biometric-driven solutions designed for real-world impact.As a healthcare technology expert, I’ve long witnessed the gaps in digital health solutions when it comes to addressing burnout and well-being at scale. What struck me in this conversation is Franceschetti’s bold assertion: sleep is not just a wellness perk, it is a foundational form of preventive care. In a field where clinicians are constantly on call, managing life-or-death decisions, and working under relentless pressure, sleep should not be optional—it should be engineered and protected like any other critical health asset.We take a deeper dive into the data—statistics that are as concerning as they are compelling. One in three physicians report burnout. Healthcare workers sleeping less than seven hours per night face significantly higher rates of emotional exhaustion and clinical error. Franceschetti and I align on this point: the status quo isn’t just insufficient—it’s dangerous. Traditional wellness programs and sleep advice often ignore the deeply individualized nature of sleep, failing to account for how factors like genetics, shift work, stress hormones, and environmental disruption shape sleep architecture.Eight Sleep’s approach is different. By leveraging real-time bio-signals—like heart rate variability, respiratory rate, and temperature—their platform continuously adapts to the sleeper’s unique physiology, effectively becoming a dynamic sleep coach embedded in your bed. This is the kind of precision health tool that healthcare has been missing.From my vantage point in digital health innovation, Franceschetti’s work represents a promising shift toward preventive infrastructure rather than reactive treatment. As our system grapples with workforce shortages—only 70% of nurses remaining in practice, rising physician dropout rates—sleep tech could be a quiet but powerful lever. It’s not just about better rest; it’s about clinical accuracy, mental resilience, patient outcomes, and system-wide efficiency.We close the conversation by exploring how sleep optimization could become a strategic pillar in the healthcare system of the future. Franceschetti argues—and I agree—that investing in personalized sleep technology could yield downstream benefits: fewer medical errors, improved staff retention, better patient satisfaction scores, and lower long-term care costs.In an era where burnout threatens the very sustainability of care delivery, Eight Sleep’s technology isn’t just a consumer innovation—it’s a potential public health intervention.AboutMatteo Franceschetti is the Co-Founder and CEO of Eight Sleep, the sleep fitness company he established in 2014 in San Francisco. A native of Italy who was obsessed with performance from a young age as a competitive ski racer, tennis player, and car racer, Franceschetti transitioned from working in the top tier of the international legal world and founding two clean-tech companies before age 30 to revolutionizing sleep technology. Under his leadership, Eight Sleep has developed proprietary technology that uses cutting-edge AI and machine learning models to track bio signals during the night and oSupport the show

I’ve always been fascinated by the mystery behind our choices — why we hit snooze instead of going for a walk, why we reach for comfort food even when we know better, and why some people seem to have the willpower to make healthier decisions with ease. This week on HLTH Forward, I had the absolute privilege of diving deep into those questions with Dr. Michael Platt, a renowned neuroscientist who’s reshaping how we understand decision-making and the human brain.Dr. Platt holds joint appointments in neuroscience, psychology, and marketing at the University of Pennsylvania and leads the Wharton Neuroscience Initiative. His work isn’t just academic — it’s deeply human, grounded in the belief that understanding how our brains work can help us live healthier, more connected, and more intentional lives.We talked about what really goes on inside our brains when we face health choices — whether it's picking between a salad or fast food, deciding to work out or stay on the couch, or even choosing to trust a physician. Dr. Platt broke down how our brains weigh risks and rewards, and how subtle shifts in awareness and intention can lead to profound changes in behavior.Some of my favorite insights:A decision is a decision is a decision. Whether it’s about health, love, or leadership — the same brain circuits are at play.Intentionality is key. Slowing down gives your brain time to override impulsive behaviors and choose long-term rewards.Trust matters. The people and environments around us dramatically shape our health decisions.Habit > willpower. Make good decisions easier by reducing friction and turning them into routines.Healthier brains make healthier lives. Dr. Platt’s three keys? Move your body, connect with others, and keep your mind active.He also shared the story behind his neuroscience startup, Cogwear, which is bringing clinical-grade brain data to the real world — helping individuals, teams, and even couples better understand how they think, feel, and connect.What I loved most about this conversation was how practical it was. Dr. Platt doesn’t just study the brain — he gives us tools to work with it. If you’ve ever felt stuck in unhealthy patterns or wondered why you know better but don’t do better, this episode is for you.AboutMichael L. Platt is a neuroscientist, psychologist, and anthropologist whose work focuses on what makes us human. His mission is to use these insights to help us achieve our best selves—at work, at home, and in the community. His principal questions focus on the biological mechanisms that underlie decision-making in social environments, the grasp of which has broad-scale implications for improving human performance, mental health, and wellbeing in societies worldwide. He is the James S. Riepe University Professor at the University of Pennsylvania, with appointments in the Perelman School of Medicine, the School of Arts & Sciences, and the Wharton School. Platt works at the intersection of economics, psychology, and neuroscience. As the Director of the Wharton Neuroscience Initiative, Platt leads efforts to connect brain science and business. He is also the founder of Cogwear, a neurotechnology company developing wearable devices that provide clinical-grade cognitive feedback. Platt has authored over 170 peer-reviewed papers and over 60 review and opinion papers. His work has been supported by the National Institutes of Health, the Klingenstein Foundation, the McDonnell Foundation, and the Department of Defense, among others. He has been featured in the New York Times, Washington Post, Wall Street Journal, Newsweek, the Guardian, and National Geographic, as well as on ABC’s GooSupport the show

In this episode I had the opportunity to interview a fascinating behavioral scientist and former CEO of Four Day Week Global about the concept of reduced working hours- Dr. Dale Whelehan. He explained how his interest in this field began when observing surgeons suffering from impaired decision-making and emotional regulation due to excessive working hours. What struck me most was his insight that today's workforce has fundamentally changed since the five-day workweek was introduced – we've shifted from physical, repetitive labor to highly cognitive work, yet human attention spans remain limited to about 3.5 hours of optimal performance daily. He emphasized that a four-day workweek isn't merely about cutting hours but redesigning work to eliminate unproductive time, with pilot studies across multiple countries showing reduced stress, better recovery, increased productivity, and improved business outcomes.During our conversation, I was particularly moved by his observations about the broader personal and societal impacts of reduced working time. People report sleeping more, exercising more, and having greater time for family, friends, and community engagement. Women especially report higher levels of wellbeing, helping close persistent gender gaps. He shared a compelling perspective on how work has become a "de facto religion" in our society as we worship productivity at the expense of human connection. When I asked about the future of healthcare, his response was thought-provoking: AI will transform knowledge requirements for healthcare professionals, creating an opportunity to refocus on interpersonal connections and compassionate care. He cautioned that we must address systemic issues of recruitment and retention rather than simply attracting healthcare workers from countries that need them most – a perspective that left me contemplating the global ethics of our current healthcare systems.About Dr. Dale Whelehan is a behaviour scientist with a diverse range of experience comprising human capital, culture, change management, workforce experience, performance consulting, organisational behaviour, and representation and rights.Having originally trained as a physiotherapist, Dale completed a PhD exploring the impact of fatigue and sleep deprivation in healthcare workers, particularly surgeons, and has published extensively in this field. More recently, Dale was a senior human capital consultant for Deloitte Ireland where he specialised in behavioural science implementation to enable large scale organisational change. Considered an expert in the field of wellbeing, Dale is passionate about the intrinsic role work plays in fatigue and performance - and how shorter working hours can bring about radical transformation for people's health and happiness.Support the show

In this episode I am in conversation with Othman Laraki, co-founder and CEO of Color. Othman shared his fascinating journey from tech to healthcare, driven by personal cancer experiences in his family. He and his mother are carriers of the BRCA2 gene mutation, which predisposes them to certain cancers.Color began as a cancer genetics company focused on making testing more affordable and accessible. Over time, they evolved into a full-spectrum cancer solution with a virtual cancer clinic model in partnership with the American Cancer Society. Their innovative approach brings healthcare to people where they are, rather than requiring patients to seek it out.Key highlights from our conversation:Color has served over 7 million people across the US and expects to reach 2 million through their virtual cancer clinic by the end of 2025They're addressing the critical issue of early detection, as early-stage cancers now have survivorship rates in the high 90% rangeThe company runs a 50-state medical group, combining testing with clinical services and logisticsThey've pioneered a novel AI approach combining OpenAI's frontier models with "large language expert" systems that transform clinical guidelines into programmatic frameworksOthman shared that cancer rates are increasing among younger populations, making preventive screening and early detection more crucial than ever. He emphasized how friction in healthcare disproportionately impacts less affluent populations, and how Color works to reduce these barriers.His three key takeaways for the future of healthcare:We need a "warp speed mindset" to tackle specific health challenges directlyEmployer-driven, vertical-focused solutions are showing real impact on outcomes and costsAI has the potential to transform healthcare more than any other industry by democratizing expertiseOur discussion revealed how technology can make healthcare more accessible while maintaining human connection - Color has operated over 14,000 physical sites in communities across America, bringing services directly to people's lives.About Othman Laraki, Chief Executive OfficerOthman Laraki a technology entrepreneur and investor and is CEO of Color Health. Othman was an early Product leader at Google, where he worked on performance infrastructure and client-side software, including the Google Chrome browser. After leaving Google, he co-founded MixerLabs, which was one of Twitter's first acquisitions. At Twitter, Othman was the Vice President of Product, helping create the company's first revenue products and grow the user base from 50 to 200 million users. After leaving Twitter, Othman co-founded Color Health, which he has been leading for the past ten years. Color is a platform for healthcare delivery, providing the technology, infrastructure, and logistics required to distribute large-scale health initiatives to diverse populations. Color works with employers, unions, and government agencies to provide equitable, accessible healthcare services. Color has served tens of millions of people across its programs and most recently has partnered with the American Cancer Society to provide a comprehensive cancer solution for large populations. Othman holds degrees in computer science and management from Stanford University and the Massachusetts Institute of Technology. He is a long-time investor and advisor to leading companies such as Pinterest, AngelList, Slack, Instacart, Gitlab, and others.Support the show

In this episode, I’m sitting down with Jason Carter — grandson of President Jimmy Carter and a force in global health and justice in his own right. As we talk, Jason reflects on the unique balance of carrying a legacy while forging his own path. He shares how his work — from the Georgia Senate to chairing the Carter Center — is rooted in impact, not just identity. He’s thoughtful, grounded, and refreshingly open as he walks us through the shifts he sees in global public health, especially in a post-Covid world, where our interconnectedness is more real than ever.Throughout the conversation, Jason keeps bringing us back to what truly matters: people. Whether we’re talking about eradicating Guinea worm in Uganda or building trust with communities in Mali, he makes it clear that real change comes from deep relationships, not surface-level aid. We dive into how the Carter Center’s “boots and roots” approach — building long-term, locally led partnerships — is creating powerful, sustainable change. He opens up about the role of trust, technology, and even business in shaping the future of health equity, reminding us that solutions don’t just live in labs — they live in people.And as we wrap, the energy is still buzzing. Jason drops insights about purpose, legacy, and the surprising value of simplicity — stories that make you pause, reflect, and rethink what it means to make a difference. This isn’t just a conversation; it’s a moment. One that, as the Japanese phrase goes — ichigo ichie — happens only once in a lifetime.About Jason Carter is an American attorney and politician who served as a member of the Georgia State Senate from 2011 to 2015. A member of the Democratic Party, he gained prominence as a candidate for governor of Georgia in 2014, where he challenged incumbent Republican Nathan Deal. Carter is also the grandson of former U.S. President Jimmy Carter. Throughout his career, he has focused on issues such as education, healthcare, and economic equality. Known for his advocacy for working families and his commitment to public service, Carter has also worked as a civil rights attorney and a community leader.Support the show

I'm diving into a fascinating topic this episode: how global tariff increases affect our wallets and social connections. With global tariff rates up 57% since 2021, households are spending 7-11% more on consumer goods, leading to a 14% decrease in social spending for every 5% increase in essential goods pricing. The health implications are significant - reduced social interaction correlates with increased depression, chronic stress, and loneliness. I'll share compelling data from countries worldwide showing how economic pressures are forcing people to cut back on social activities.The good news is communities are developing creative solutions that I'm excited to explore. I'll highlight three approaches: resource-sharing systems like tool libraries and childcare exchanges that reduce costs while building relationships; rediscovering free social activities with park usage up 42% in tariff-affected areas; and consistency over frequency in social interactions. I'll share stories from communities worldwide who've found that navigating economic challenges together often creates stronger bonds than before. The episode will conclude with practical suggestions for maintaining social connections despite financial constraints, emphasizing that meaningful connections don't require significant spending.AboutSupport the show

In our candid conversation leveraging Fast Company's September 2024 feature, Dr. Oliver Kharraz reveals the harsh realities of healthcare technology innovation. "When we launched ZocDoc in 2007, I watched wave after wave of self-proclaimed 'disruptors' enter the healthcare arena like lions, only to retreat like lambs," he shares, pointing out that 90% of healthtech startups have gone bust. The stark truth is that even tech giants like Amazon, Apple, and Google have struggled to make meaningful inroads in an industry that resists quick fixes. With America spending $4.8 trillion on healthcare annually and 73% of adults feeling the system is failing them, Kharraz argues that the solution isn't radical disruption, but what he calls "inside-out pragmatism" – a methodical, patient approach that understands and works within the existing healthcare ecosystem.Diving into the seven critical challenges facing healthtech, Kharraz pulls back the curtain on the industry's complex landscape. From the fragmentation of 340,000 physician practices running on hundreds of electronic health record systems to the intricate dance of stakeholder incentives, he emphasizes that healthcare technology can't be treated like any other consumer sector. "Moving fast and breaking things simply doesn't work when people's lives are at stake," he explains, recounting ZocDoc's own near-death experience navigating regulatory ambiguities. The most profound insight emerges in his belief that technology's role is not to replace healthcare providers, but to connect, enhance, and incrementally improve a system that requires deep understanding, patience, and a commitment to solving complex problems one step at a time. For Kharraz, the future of healthcare technology lies not in disruption, but in pragmatic, thoughtful innovation that respects the nuanced human elements of medical care.AboutOliver Kharraz, MD, is CEO and founder of Zocdoc. Oliver is the most recent doctor in a 300-year family tradition. Over the course of his wide-ranging career, Oliver has accrued comprehensive experience effecting change and building efficiency in large scale healthcare organizations using information technology.Support the show

In this episode I am in conversation with Jeff Jacques, CMO of Personify Health, who reveals the harsh realities of our one-size-fits-all healthcare system. We'll explore alarming metrics showing how standardized approaches contribute to the $4.3 trillion annual US healthcare expenditure (nearly 20% of GDP), while 30% of medical spending—approximately $760-$935 billion—is wasted on unnecessary treatments and inefficiencies. Jeff will highlight how non-personalized care leads to the 13-20% hospital readmission rates costing Medicare alone $26 billion annually, and explain why medication non-adherence affects nearly 50% of patients with chronic conditions, resulting in 125,000 preventable deaths each year.Jeff shares Personify Health's groundbreaking approach that's transforming healthcare delivery through their proprietary assessment methodology and AI-driven platform. He elaborates how their unique services—from personalized chronic disease management to customized mental health support—are producing measurable improvements in patient outcomes while reducing costs by up to 25% for participating systems. With 60% of Americans having at least one chronic condition (accounting for 90% of healthcare spending), this conversation promises to illuminate how Personify Health's patient-centered technology is pioneering a future where healthcare finally acknowledges that each patient's journey is as unique as their fingerprint, potentially saving billions while significantly improving quality of life for millions of Americans.AboutJeff Jacques, MD, is a physician executive leader and entrepreneur who has spent more than 20 years in digital health, building products and services that deliver personalized support for individuals experiencing complex care journeys. As Chief Medical Officer at Personify Health, he focuses on ensuring alignment with member and market needs, enhancing the company’s behavior science approach, and exploring additional ways its unique capabilities can further simplify and support the member journey.Jeff’s personal experiences and frustrations with the healthcare system ignited a passion for solving complex health problems, driving much of his career. He was previously CEO and co-founder of CareTribe, a digital health platform dedicated to supporting the needs of family caregivers. It was acquired by family support company Cleo in 2022. He also held leadership roles with CVS Health/Aetna for more than a decade, including as founder of NeoCare Solutions, a CVS Health/Aetna business supporting the parents of premature infants in the NICU, and as chief clinical innovation officer at ActiveHealth Management, a CVS Health company.Jeff was a member of the Food and Drug Administration Safety Innovation Act (FDASIA) Workgroup and has held several non-profit board positions. He trained in Internal Medicine at St. Luke’s-Roosevelt Hospital, part of the Mount Sinai system in NYC.Support the show

In this episode, I am in conversation with with the President and Co-Founder  of Komodo Health to explore how their revolutionary healthcare journey mapping is transforming patient care in ways no other company has achieved.What sets Komodo Health apart is their proprietary Healthcare Map™ – the industry's largest and most comprehensive patient-level database that tracks nearly 330 million Americans' interactions with the healthcare system. Unlike traditional data aggregators, Komodo has created an interconnected ecosystem that links clinical encounters, prescription data, insurance claims, lab results, and social determinants of health into a unified, longitudinal view.We dive into how Komodo's unique artificial intelligence and machine learning capabilities extract actionable insights from this massive dataset, identifying patterns invisible to traditional analytics. Web explains their distinctive approach to tokenization and de-identification that maintains patient privacy while enabling unprecedented analytical depth across the entire patient journey.I seek to understand how Komodo's platform differs from competitors by enabling not just retrospective analysis but predictive modeling that helps healthcare providers anticipate patient needs before they develop complications. We'll explore their innovative Sentinel system that alerts care teams to intervention opportunities based on real-world evidence rather than theoretical care pathways.Throughout our conversation, we examine how this comprehensive approach allows Komodo to address healthcare disparities by identifying gaps in care that other platforms simply cannot detect. Web shares case studies of how their technology has revolutionized rare disease diagnosis, reduced care variation, and optimized treatment pathways in ways that were impossible before their platform existed.This fascinating conversation reveals how Komodo Health's distinctive data-driven insights are not just improving individual patient outcomes but transforming our entire approach to healthcare delivery.AboutWeb Sun, the President and Co-Founder of Komodo Health, has dedicated his career to making a meaningful impact on healthcare. He began as a cancer researcher, followed by a decade working with Fortune 100 companies in research and development, before ultimately moving into health technology. Throughout his career, he became increasingly focused on the power of data and analytics in shaping critical decisions within the healthcare system. His passion for leveraging data and emerging technologies led to his current role at Komodo Health.Support the show

In a groundbreaking conversation, Wei Li, President of Omada Health, outlined a transformative vision for healthcare deeply rooted in a profound belief that health is a fundamental human right. Drawing inspiration from a World Health Organization quote that "help is the core of sustainable development," Li has dedicated his entire professional career to addressing the universal health challenges people face globally. His approach seamlessly integrates technology and human connection, focusing on comprehensive, personalized care across chronic conditions like diabetes, hypertension, and musculoskeletal issues. Li emphasizes that the real healthcare challenge lies not in medical appointments, but in the day-to-day struggles people face in implementing health changes, believing that health is the foundational element for achieving life's personal and professional objectives.Central to Omada Health's strategy is a delicate balance between AI-driven solutions and human coaching, with Li asserting that human relationships remain the critical "currency" of behavior change. The company leverages billions of health data points to create highly personalized care experiences, particularly in innovative areas like GLP-1 medication management and behavioral intervention programs. By prioritizing accessibility, continuous support, and a holistic view of patient needs, Omada Health is fundamentally reimagining healthcare delivery—making it more integrated, proactive, and centered on individual patient experiences across diverse populations. Li envisions a future where healthcare becomes as accessible and routine as daily personal care, breaking down traditional barriers between in-person and virtual health services, and providing persistent, personalized support that recognizes the complex interplay of health challenges faced by patients.About Wei Li is a global executive and leader with over 20 years of experience building and leading biopharmaceutical, diagnostic imaging, and digital health businesses across the world. After a rewarding 18-year career at Eli Lilly and Company, he came to Omada Health in 2019 to take on a new professional challenge––upending the status quo in chronic condition care by scaling virtual health. Currently, 70% of U.S. healthcare spending is for people with chronic conditions. He is steadfast in his belief that Omada is at the forefront of health tech innovation that's gradually improving outcomes and reducing costs for health systems and organizations.He holds dual Bachelor of Science degrees in biochemistry and molecular biology from the University of Wisconsin-Madison and a Master of Business Administration from the Kelley School of Business, Indiana University. Over the course of his career, he has demonstrated an ability to grow successful organizations, lead turn-arounds, and establish start-ups. He has brought his wealth of experience to Omada, where he has surrounded himself with amazing people, built a strong team, set high expectations, and helped create an organization grounded in values and principles.In addition to his professional achievements, Li has published a children's book, "Anny The Tall Girl," a touching story imbued with diversity, equity, and inclusion. He and his wife Sarah are the proud parents of two daughters.Support the show

Medtronic's technological strategy represents a sophisticated convergence of AI, data analytics, and medical innovation, positioned to fundamentally reshape healthcare delivery. Under Chief Technology Officer Ken Washington's leadership, the organization is pioneering a model of technological augmentation that prioritizes human expertise while leveraging advanced computational capabilities. The core strategic approach focuses on developing intelligent medical devices that provide precision insights and predictive healthcare interventions.The technology framework centers on comprehensive data infrastructure, spanning 70 distinct medical conditions. By meticulously collecting and analyzing patient data through advanced sensing technologies, Medtronic is developing AI-enabled platforms capable of personalized health monitoring and preemptive diagnostic capabilities. This approach transforms medical technology from a reactive to a predictive model, potentially reducing healthcare costs and improving patient outcomes through early intervention strategies.Washington's innovation model extends beyond technological development to include critical considerations of regulatory compliance, global scalability, and sustainable design. With a commitment to net-zero emissions by 2045 and strategic partnerships across healthcare and technology sectors, Medtronic is positioning itself as a leader in responsible, forward-thinking medical innovation. The organization's approach integrates high-precision robotics, advanced algorithmic models, and data-driven personalization to create transformative healthcare solutions that address complex global health challenges.AboutKen Washington serves as Senior Vice President and Chief Technology and Innovation Officer. In this role, Ken is responsible for accelerating Medtronic innovation through product development and technology strategies.Ken joined Medtronic in 2023 and brought with him deep expertise in leading technology development and execution across industries including robotics, consumer products, automotive, and space. Ken inspires teams and pushes them even further in their ability to invent, innovate and create positive market disruptions. He partners closely with teams and leaders around Medtronic to ensure our products and therapies continue to advance the Mission to better serve patients and customers.Prior to joining Medtronic, Ken was Vice President and General Manager of Consumer Robotics at Amazon. Prior to that, he was Chief Technology Officer at Ford Motor Company, overseeing development of the company’s technology strategy including next-generation vehicle architectures, controls and automated systems. He also spent seven years at Lockheed Martin in various leadership roles including Chief Technology Officer, Chief Privacy Officer and Vice President, Advanced Technology Center, Lockheed Martin Space Systems Company.Ken is an internationally recognized thought leader on technology and innovation. He earned a Bachelor of Science, a Master of Science, and a PhD in nuclear engineering from Texas A&M University. He was inducted into the National Academy of Engineering in 2020 and was inducted into the Black Engineer Hall of Fame in 2023.Support the show

95% of rare diseases do not have approved treatments, highlighting the significant unmet need in the rare disease community.The unpredictable symptoms and long diagnostic process for conditions like neuromyelitis optica spectrum disorder (NMOSD) can lead to debilitating long-term disabilities.There is an urgent need for increased education, resources, and support to address the global diagnostic challenge and financial burden on rare disease patients and their families.Tamar shares her inspiring healthcare journey, starting as a provider and then transitioning to the life sciences industry after marrying an Air Force member and moving to North Dakota. She now advocates for the rare disease community, particularly focusing on NMOSD, a rare autoimmune disorder that affects the central nervous system. Tamar explains that while there are an estimated 7,000-10,000 rare diseases, only 5% have approved treatments, and 90% of these diseases do not have any approved treatmentsThe symptoms of NMOSD can be unpredictable and lead to long-term disabilities like vision loss and paralysis. Tamar emphasizes that the journey to diagnosis for rare disease patients can be long, often taking 7 years on average, and that NMOSD is more common in women in their mid-30s, though it can also affect men and children. Tamar discusses the challenges in diagnosing rare diseases like neuromyelitis optica spectrum disorder (NMOSD)Rare diseases are often genetic in nature, making diagnosis difficult as symptoms can be ambiguous. Tamar highlights Alexion's history of pioneering research and development in the rare disease space, including complement-based therapies and the promise of cell and gene therapies. She emphasizes the global nature of the diagnostic challenge, with patients often seeing multiple specialists before receiving the correct diagnosisTamar highlights the significant financial burden on families dealing with rare diseases, with costs 10-20 times higher annually. She also touches on the promise of advancing technologies, like genome sequencing, to help with earlier diagnosis, but emphasize that access and affordability remain challenges. Overall, the discussion sheds light on the struggles faced by those impacted by rare diseases and the need for more education, resources, and support for patients and their caregiversThe discussion highlights the significant challenges faced by rare disease patients and their families, including the high financial burden and lack of awareness and support. There is a need for increased education, policy changes, and investment to foster rare disease diagnosis, treatment, and access to care. We share the call for urgent action to address these issues and prepare for the future, given the aging population and the potential for a "silent epidemic" if left unaddressed. We discuss the challenges of diagnosing rare diseases, emphasizing the need for greater education and awareness among medical professionals. Support the show

In this episode I sit down with a good friend and mentor Rob Fried, CEO of ChromaDex, who shares his remarkable transition from Hollywood executive producer to leader of a cutting-edge nutraceutical company. Fried's journey from producing films like Rudy and Godzilla to helming a science-focused organization dedicated to extending human healthspan showcases the power of reinvention and following one's passion.Through ChromaDex's pioneering research into NAD+ and cellular health, Fried has positioned himself at the intersection of scientific innovation and consumer wellness, bringing Hollywood storytelling skills to communicate complex scientific concepts to a broader audience.The conversation delves deep into the crucial role of NAD+ in cellular health, particularly its impact on mitochondrial function – our cells' power plants. As Fried explains, our NAD+ levels naturally decline with age, accelerated by modern lifestyle factors like poor sleep, excessive alcohol consumption, and environmental stressors. We explore the growing need for consumer education in the supplement industry and draw compelling parallels between the responsible AI movement and the necessity for ethical governance in the supplement space. Fried advocates for establishing a responsible supplement board to ensure product quality, ingredient sourcing transparency, and consumer safety – addressing the current regulatory gaps in the industry.Buy Here- Upgrade your cellular Health About NAD+NAD+ (Nicotinamide Adenine Dinucleotide) serves as a fundamental molecule in cellular health, playing multiple vital roles throughout the body. At its core, NAD+ is essential for energy production, working within our mitochondria to convert food into usable cellular energy. Beyond energy production, it acts as a crucial coenzyme for hundreds of biological processes, including DNA repair, gene expression regulation, and cellular stress response. NAD+ activates important proteins called sirtuins, which are often referred to as "longevity genes" due to their role in promoting healthy aging and cellular maintenance. As we age, our natural NAD+ levels decline, potentially contributing to various age-related conditions and decreased cellular function. This decline affects multiple aspects of health, including cognitive function, muscle strength, metabolic health, and cardiovascular wellness. Research has shown that maintaining healthy NAD+ levels can support improved energy levels, enhanced cellular repair, better brain function, stronger immune response, and more efficient metabolism. The molecule's influence extends to supporting liver health, promoting muscle recovery after exercise, regulating circadian rhythms, and potentially protecting against various age-related diseases, making it a crucial target for research in healthy aging and longevity science.About Rob FriedRobert Fried is the Chief Executive Officer (CEO) of ChromaDex. Mr. Fried is an Academy Award and Emmy Award-winning motion picture producer.  He has held senior roles at entertainment companies Savoy Pictures (CEO), Columbia Pictures (Executive Vice President), and Fried Films (founder, CEO).  He has also founded and served as CEO of internet companies Feeln (now Hallmark Movies Now), WHN (a leading e-commerce service provider), and Healthspan Research (now part of ChromaDex). Mr. Fried holds a B.S. from Cornell University and an M.B.A. from the Columbia University Graduate School of Business.Support the show

In this episode I am in conversation with Matthew Holt, a prominent figure in health technology and policy;  an uncensored discussion on the current state of healthcare. Known for his frank and often controversial opinions, Holt is expected to delve into pressing issues such as the impact of artificial intelligence on medical practices, the ongoing challenges of healthcare affordability, and the slow pace of digital transformation in the industry. We'll explore his views on why many promised healthcare innovations have failed to deliver and what he believes are the most promising solutions on the horizon.The interview will also touch on sensitive topics that often go undiscussed in mainstream healthcare conversations. Holt may share his unfiltered thoughts on the influence of big pharma and insurance companies, the shortcomings of current health policies, and the real-world consequences of a fragmented healthcare system.AboutMatthew Holt is the founder and publisher of The Health Care Blog and still writes regularly for the site and hosts the #THCBGang and #HealthInTwoPoint00 video shows/podcasts. He was co-founder of the Health 2.0 Conference and now also does advisory work mostly for health tech startups at his consulting firm SMACK.health.Support the show

I had the privilege of sitting down with Interwell Health's CEO, Robert Sepucha to explore the future of kidney care in America. The statistics are sobering - chronic kidney disease impacts an estimated 37 million U.S. adults, with over 500,000 relying on dialysis. As I listened to Bobby's insights, it became clear that innovative care models aren't just desirable but crucial. Interwell Health is tackling this challenge head-on, and I was fascinated to learn about its value-based approach. Their mission to improve patient outcomes while simultaneously reducing the enormous $114 billion annual Medicare spending on kidney disease is both ambitious and inspiring.Our discussion deeply explored what makes Interwell unique. The merger of Fresenius Health Partners, Cricket Health, and Interwell Health has created a powerhouse in kidney care, and I was eager to understand how this combination translates to better patient care. Bobby's explanation of their integrated care model was eye-opening. By marrying Acumen EHR's sophisticated data analytics with hands-on nephrology expertise, they're reimagining the entire patient care journey. What struck me most was how this approach extends beyond just managing the disease - it's about empowering patients, particularly through increased access to home-based care optionsAboutAs Chief Executive Officer, Bobby leads Interwell Health’s overall strategy and is passionate about helping patients live their best lives while delivering results for payers and providers. Bobby brings over ten years of value-based kidney care experience to his role, having served as CEO of Cricket Health and as a senior executive in policy and corporate affairs at Fresenius Medical Care. He has long worked at the intersection of business, policy, and law, having served as chief of staff to a member of Congress and General Counsel at the Massachusetts Life Sciences Center. He also practiced as an attorney with Gunderson Dettmer in Silicon Valley and Boston where he represented venture capital firms and high-tech startups. Bobby received a Juris Doctor degree from the University of Michigan and a BA degree from Dartmouth College.Support the show

In this episode, I am in conversation with Viz.AI CEO, Dr. Chris Mansi, a pioneer in leveraging artificial intelligence for early disease detection. Our discourse unveiled the revolutionary strides Viz.ai has made in the medical field, particularly in neurovascular and cardiology domains. Dr. Mansi elucidated how their AI-powered platform has dramatically reduced time-to-treatment for stroke patients, citing their flagship product that can detect large vessel occlusions in CT scans within minutes, enabling rapid triage and intervention.Their AI algorithms have shown remarkable efficacy in detecting pulmonary embolisms and aortic dissections, conditions where timely diagnosis can mean the difference between life and death. Dr. Mansi shared a poignant case study where their AI platform identified a subtle aortic abnormality that human radiologists had initially overlooked, potentially averting a catastrophic outcome.In the United States alone, it's estimated that diagnostic errors contribute to 40,000 to 80,000 deaths annually. Furthermore, approximately 12 million adults annually experience diagnostic errors in outpatient settings. Chris emphasized that their AI tools are not meant to replace human expertise but to augment it, creating a synergy that promises to revolutionize patient outcomes. By providing rapid, accurate medical imaging analyses, Viz.aAI's technology empowers healthcare providers to make swift, informed decisions, potentially saving thousands of lives each year. This harmonious blend of artificial intelligence and human insight represents a new frontier in medicine, where the early detection of diseases becomes a possibility and a standard of care.About Viz.ai, Inc. is emerging as the leader in applied artificial intelligence in healthcare. Our mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce time to treatment and improve access to care. Our flagship product, Viz LVO, leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat. In February 2018, the U.S. Food and Drug Administration (FDA) granted a de novo clearance for Viz LVO, the first-ever computer-aided triage and notification platform. Most recently, Viz.ai announced its second FDA clearance for Viz CTP through the 510(k) pathway, offering healthcare providers an important tool for automated cerebral image analysis.Support the show

In this episode, we explore the groundbreaking fusion of virtual reality and mental health with Nanea Reeves, the innovative CEO and founder of TRIPP. With nearly 1 in 5 adults in the U.S. experiencing mental illness each year, and global depression rates rising by 28% since 2020, the need for novel therapeutic approaches has never been more urgent. Nanea's journey into this space isn't merely a business venture; it's a deeply personal mission rooted in her experiences and an unwavering commitment to improving lives.We'll delve into how TRIPP leverages the immersive power of VR to revolutionize mindfulness and emotional well-being. Our discussion will address a fascinating paradox: while some view VR as a potential escapism, it's proving to be a powerful tool for confronting and managing mental health challenges. For instance, we'll explore how veterans, who often struggle with PTSD, find unexpected comfort in interacting with avatars rather than humans, free from the fear of judgment.Our conversation will navigate the unique hurdles of developing mental health technology, VR's potential to democratize access to wellness practices, and the delicate balance of harnessing technology while mitigating concerns about digital overwhelm. Nanea's insights will offer listeners a glimpse into a future where cutting-edge technology and compassionate, human-centered design converge to transform mental health care.AboutNanea Reeves founded TRIPP, an award-winning global XR Wellness company, following a tremendous personal loss that led her to rethink her life’s purpose. With a lifelong meditation practice that began in her teens, Nanea recognized its transformative powers, and she wanted to figure out a way to make meditation more accessible to people around the world. TRIPP was the solution, which married her meditation practice with her love of video games and her extensive software development experience. Through interactive, immersive experiences that combine gameplay mechanics, mindfulness structures, and psychedelic-inspired environments, users are guided into powerful, awe-inspiring, transformative states. Ultimately, TRIPP aims to empower people to take control of their mental and emotional well-being wherever they are.Nanea brings over 15 years of experience in digital distribution, video game technologies, and mobile application development. Before co-founding TRIPP, Nanea was President and COO of textPlus, one of the top mobile communications applications. Nanea was also COO at Machinima, the largest gaming network on YouTube that was acquired by Warner Brothers, Chief Strategy Officer at Gakai (acquired by Sony) and she was the Senior Vice President and COO of Global Online at Electronic Arts who acquired JAMDAT, the mobile game start-up that Nanea ran technology at. Through her leadership at these previous companies, she’s facilitated $1.6 billion in exits.Support the show

In this episode, I am in conversation with Seema Verma, Executive Vice President and General Manager at Oracle Health & Life Sciences.Seema shared her insights into the company's innovative approaches to transforming healthcare. Verma highlighted Oracle Health's focus on leveraging advanced technologies such as artificial intelligence, cloud computing, and data analytics to streamline healthcare delivery and improve patient outcomes. She emphasized the importance of interoperability in healthcare systems, explaining how Oracle's solutions facilitate seamless data exchange between healthcare providers and institutions. Verma also discussed Oracle Health's efforts to enhance patient engagement through personalized digital health tools and their work on predictive analytics to support preventive care initiatives.Drawing from her experience as the former Administrator of the Centers for Medicare and Medicaid Services (CMS), Verma provided a unique perspective on the intersection of healthcare policy and technology. She reflected on how her tenure at CMS, where she oversaw critical programs like Medicare and Medicaid, informed her current role at Oracle Health. Verma explained how this background helps her navigate the complex regulatory landscape of healthcare while driving innovation. She also discussed the potential of Oracle Health's solutions to address some of the longstanding challenges in healthcare delivery that she encountered during her time at CMS, such as reducing administrative burdens, improving cost transparency, and enhancing the quality of care for millions of Americans.AboutSeema Verma serves as the Executive Vice President and General Manager at Oracle Health, where she leverages her extensive experience to drive innovation and transformation in healthcare technology and delivery. A  prominent American healthcare policy expert who served as the Centers for Medicare and Medicaid Services (CMS) Administrator from 2017 to 2021 during the Trump administration. Born in 1970 to Indian-American parents, Verma holds a bachelor's degree in life sciences from the University of Maryland and a master's in public health from Johns Hopkins University. Before her CMS role, she founded SVC Inc., a health policy consulting firm. At CMS, Verma oversaw the marketplace of Medicare, Medicaid, and the Affordable Care Act, focusing on market-driven reforms, state flexibility, price transparency, and healthcare technology modernization. Known for her efforts to reform government health programs and advocacy for consumer-driven healthcare policies, Verma has continued to be influential in the healthcare sector. Support the show

Global aging trends show a significant shift in demographics, with approximately 10% of the world's population aged 65 and over. This proportion is expected to double by 2050, reaching about 1.5 billion people. The old-age dependency ratio, currently at about 14 elderly per 100 working-age individuals globally, is projected to increase substantially in the coming decades. Additionally, the number of centenarians worldwide, estimated at 573,000, is expected to grow more than sixfold by 2050, reaching 3.7 million.In this captivating episode, I delve into aging research with Dr. Valter Longo, a renowned expert who challenges conventional wisdom on longevity and nutrition. Dr. Longo explores whether aging should be classified as a disease or viewed as a natural life process, sharing insights from his centenarian studies. He introduces his research-based "Longevity Diet," designed to extend health span and potential lifespan while debunking the prevalent "protein culture" myth that encourages excessive protein consumption.Dr. Longo's approach to aging is both refreshing and thought-provoking. Rather than viewing aging as something to be avoided, he advocates for embracing it gracefully through proper nutrition and physical activity. This perspective, combined with practical advice drawn from his extensive research, offers listeners a new way to think about and optimize their aging process. The episode provides valuable insights for anyone interested in living a longer, healthier life, making it a must-listen for those curious about the science of longevity and personal well-being.AboutDr. Longo studied biochemistry as an undergraduate at the University of North Texas and received his PhD in Biochemistry from UCLA, where he worked under calorie restriction guru Roy Walford, MD. He completed his postdoctoral training in neurobiology with longevity pioneer, Caleb Finch, PhD. He also received extensive training in immunology, endocrinology, microbiology, genetics, molecular biology, and pathology.His studies focus on the fundamental mechanisms of aging in simple organisms and mice and how these mechanisms can be translated to humans. The Longo laboratory has identified some of the key genetic pathways that regulate aging in simple organisms and has demonstrated that the inactivation of such pathways can reduce the incidence or progression of multiple diseases in mice and humans. His laboratory has also developed dietary and genetic interventions that protect normal cells while sensitizing cancer cells to chemotherapy— interventions are now being tested in many US and European hospitals.The Longo laboratory recently published key findings on a 5-day periodic dietary intervention called Fasting Mimicking Diet (FMD), and showed in randomized clinical trials that FMD reduces the risk factors and markers associated with aging and diseases. Dr. Longo’s most recent studies focus on the use of FMD interventions to activate stem cell-based regeneration to promote longevity.Dr. Longo has received numerous awards for his work: the 2010 Nathan Shock Lecture Award from the National Institute on Aging (NIA/NIH), the 2013 Vincent Cristofalo “Rising Star” Award in Aging Research from the American Federation for Aging Research (AFAR), the 2016 Merz Professorship, the 2016 Boehaave Professorship, the 2016 Jubilee Professorship, and the 2016 Glenn Award for research on aging. In 2018 he was named by “Time Magazine” one of the 50 most influential people in health care for his research on fasting-mimicking diets as a way to improve health and prevent disease.Support the show

The United States faces significant maternal health challenges, with a higher maternal mortality rate than many developed countries, particularly affecting women of color and those in rural areas. Against this backdrop, Maven Clinic has emerged as a leading innovator in women's and family health. As the world's largest virtual clinic in this field, Maven leverages technology to provide comprehensive, personalized care, offering a unique blend of telemedicine and care coordination services. Their platform connects patients with a diverse network of providers specializing in reproductive health, pregnancy, postpartum care, pediatrics, and more, addressing gaps in traditional healthcare systems and offering on-demand access to specialists, mental health support, and educational resources.At the helm of Maven's medical leadership is Dr. Neel Shah, widely regarded as a pioneering force in maternal healthcare. His approach to transforming maternal care is rooted in addressing systemic issues and reimagining care delivery. Dr. Shah emphasizes the critical role of trust in healthcare, arguing that trustworthiness must be actively operationalized within healthcare systems. This perspective is especially relevant in addressing the various divides in maternal care, including racial, socioeconomic, and geographic disparities. Maven's approach, guided by Dr. Shah's vision, focuses on continuity of care, supporting individuals throughout their entire reproductive journey and beyond. By integrating data-driven insights with personalized care plans, Maven has demonstrated significant improvements in maternal health outcomes, including reduced C-section rates and NICU admissions.Dr. Shah's work, in conjunction with Maven's mission, aims to bridge the divides in maternal care by advocating for more inclusive, culturally competent, and patient-centered approaches. This vision includes expanding access to quality prenatal and postnatal care, addressing social determinants of health, and fostering a healthcare environment where all mothers feel heard, respected, and supported. Maven's commitment to inclusivity and addressing health disparities has made it a valuable resource for diverse populations, including LGBTQ+ families and those facing fertility challenges. Through partnerships with employers and health plans, Maven has played a crucial role in expanding access to quality maternal and family healthcare, potentially reaching millions of individuals who might otherwise face barriers to comprehensive care. This approach not only addresses the immediate healthcare needs but also tackles the broader issues of social, emotional, and financial support throughout pregnancy and the postpartum period, areas where the United States currently lacks comprehensive systems compared to many other developed nations.About Dr. Neel Shah, MD, MPP, FACOG, is the Chief Medical Officer of Maven Clinic, the world's largest digital clinic for women's and family health. He is also a visiting scientist at Harvard Medical School where he previously served as a professor of obstetrics, gynecology, and reproductive biology. Dr. Shah has been recognized with the Franklin Delano Roosevelt Humanitarian of the Year Award from the March of Dimes for impacting maternal health in the United States. He is featured in the 2023 Emmy-nominated film Aftershock, currently streaming on Hulu and The Color of Care from the Smithsonian Channel and Executive Producer Oprah Winfrey. Dr. Shah founded the nonprofit Costs of Care and March for Moms and the Delivery Decisions Initiative at Ariadne Labs, a research and social impact program of the Harvard T.H. Chan School of Public Health.As a physician-scientist, Dr. Shah has written landmark academic papers on maternal health and healthcare policy, and contributed to fouSupport the show

As a country, we are experiencing mental health crises across all ages.  I sit down with Dr.Jenna Glover, Chief Clinical Officer at Headspace, to delve into the pressing mental health crisis in the United States. We are facing alarming statistics, including that 1 in 5 adults experience mental illness annually, 17% of youth aged 6-17 grapple with mental health disorders, and suicide ranks as the second leading cause of death among individuals aged 10-34. Against this backdrop, Glover discusses how Headspace, a digital mental health platform, addresses these challenges through accessible meditation and mindfulness tools tailored for various age groups and life circumstances,  as well as mental health coaching, therapy, and psychiatry.As we share equal concern regarding the massive shift we witness, Dr. Glover highlights Headspace's innovative approaches, such as the "Monster Meditations" program designed specifically for children, and a diverse range of exercises catering to adults from all walks of life. She emphasizes the company's commitment to equity, detailing how their research-driven methodology has improved the platform's inclusivity and effectively removed barriers to access for diverse populations. This focus on equity in both research and delivery has resulted in increased usage across different demographic groups, positioning Headspace as a vital resource in the ongoing effort to support mental health for all Americans.AboutJenna Glover is Chief Clinical Officer at Headspace, where she oversees the company’s Care Services, including coaching, therapy, psychiatry, QA and training, and care enablement teams, to ensure members receive high-quality, culturally responsive care. She previously served as an Associate Professor in the Department of Psychiatry at the University of Colorado School of Medicine, Director of Psychology Training at Children’s Hospital Colorado, and as the lead psychologist at Avalon Hills, a residential eating disorders program based in Logan, Utah. Jenna’s clinical work focuses on utilizing motivational interviewing and acceptance-based therapies across a range of internalizing disorders.Her passion is working with others to develop skillful behaviors that help create a life worth living. Jenna also provides professional and community outreach, frequently delivering talks and lectures on promoting wellness and self-care. She has also given a TED Talk on these topics. She has been honored with awards for teaching excellence, service to students, and wellness. Jenna is a licensed psychologist, and received her doctorate in Combined Clinical, Counseling, and School Psychology from Utah State University.Support the show

In a nation that cherishes freedom and democracy, the men and women who have worn the uniform and stood as guardians of our liberty deserve the utmost respect, care, and support. Dr. Shereef Elnahal, the Under Secretary of Health at the U.S. Department of Veterans Affairs, is at the forefront of this noble cause, ensuring that those who have sacrificed so much for our country receive the highest quality healthcare they deserve.With an annual budget of approximately $102.2 billion, Dr. Elnahal oversees the delivery of care to more than 9 million enrolled Veterans, a responsibility that he carries with unwavering dedication and compassion. His mission is not merely to provide medical treatment but to ensure that our nation's heroes have access to comprehensive and accessible care, addressing both their physical and mental well-being.One of the key focuses of Dr. Elnahal's work is the mental health of Veterans, particularly those grappling with the invisible wounds of war, such as post-traumatic stress disorder (PTSD). He understands that the transition from the battlefield to civilian life can be a daunting and often traumatic experience, and his approach is holistic, encompassing not only the Veterans themselves but also their families and loved ones.Dr. Elnahal recognizes that the path to healing and reintegration into society is a journey that requires a supportive ecosystem. By engaging families and communities, he aims to create an environment where Veterans can find solace, understanding, and the resources they need to manage their mental health challenges effectively.Intertwined with this mission is the transformative potential of artificial intelligence (AI) in revolutionizing Veterans' healthcare. AI has the power to enhance diagnosis, treatment, and overall patient care through advanced analytics, predictive modeling, and personalized medicine. Dr. Elnahal's vision encompasses leveraging the latest AI technologies to improve the quality of care, streamline processes, and ultimately provide Veterans with the most cutting-edge and efficient healthcare services availableAs a nation, we owe an immense debt of gratitude to our Veterans, and Dr. Shereef Elnahal's work at the Department of Veterans Affairs is a testament to our commitment to honoring their sacrifices. Through his compassionate leadership, innovative approaches, and a deep understanding of the unique challenges faced by our Veterans, he is paving the way for a future where every Veteran receives the highest standard of care, both physically and mentally, empowering them to lead fulfilling lives after their service to our country.AboutDr. Shereef Elnahal is the Under Secretary for Health at the United States Department of Veterans Affairs (VA). He was nominated by President Joseph R. Biden and confirmed by the United States Senate on July 21, 2022. As the Under Secretary for Health, Dr. Elnahal directs a healthcare system with an annual budget of approximately $102.2 billion, overseeing care delivery to more than 9 million enrolled Veterans. The Veterans Health Administration (VHA) is the largest integrated health care system in the United States, providing care at over 1,300 health care facilities, including 171 VA Medical Centers and 1,120 outpatient sites of care of varying complexity (VHA outpatient clinics). VHA is the nation's largest provider of graduate medical education and a major contributor to medical and scientific research. More than 73,000 active volunteers, 127,000 health professions trainees, and more than 362,000 health care professionals and support staff are an integral part of the VHA community.Dr. Elnahal is physician leader who previously served as President and Chief Executive Officer of University Hospital in Newark, NJ from 2019 through 2022. Dr. Elnahal led University HosSupport the show

On today's episode, I have the pleasure of speaking with Dorothy Kilroy, Chief Commercial Officer at Oura, the innovative company behind the popular Oura ring wearable device. Oura has been making waves in the health tech space by providing valuable sleep, activity, and biometric data to help people optimize their well-being.  Dorothy gives us an inside look at the technology and science behind the Oura ring. We'll learn about the key benefits and features that have made it a favorite among athletes, fitness enthusiasts, and anyone looking to elevate their health and performance. Dorothy will also share insights into Oura's groundbreaking work in areas like women's health tracking and partnerships with major sports leagues. Whether you're already an Oura user or just curious about wearable tech, this interview will be incredibly informative. So get ready to take notes as we dive into the world of sleep optimization, readiness scores, and cutting-edge health data with Dorothy Kilroy of Oura.Support the show

In an insightful interview, Dr. Giullian, Chief Medical Officer of DaVita, a healthcare provider serving over 250,000 patients annually, reveals his pioneering vision for revolutionizing kidney care. By seamlessly integrating cutting-edge technology, mental health support, nutritional interventions, and a relentless focus on preventive care and aging, Dr. G spearheads a comprehensive transformation in the nephrology field.DaVita's strategic leveraging of emerging technologies, such as cloud computing and data integration, is at the core of this revolution. Through their proprietary DaVita CWOW™ (Center Without Walls™) platform, the company is pioneering advanced collaborations across care teams and streamlining workflows to personalize treatment plans, optimize outcomes, and proactively identify risk factors for kidney disease progression. This data-driven approach enables DaVita to deliver tailored care solutions that address each patient's unique needs and circumstances.Recognizing that kidney care extends beyond clinical interventions, DaVita is implementing innovative programs like DaVita's Mindful Life Educator Program to address the psychological challenges faced by kidney patients, fostering resilience and improving quality of life. Dr. G emphasizes the importance of mental well-being in the overall healing process, acknowledging the emotional toll that chronic kidney disease can take on patients and their loved ones.Moreover, Dr. G champions DaVita's "Food as Medicine" initiative, emphasizing the crucial role of nutrition in kidney disease management. DaVita's team of renal dietitians collaborates with culinary experts to develop tailored dietary plans that cater to patients' medical needs, cultural preferences, and personal tastes. This holistic approach not only supports better health outcomes but also enhances patient satisfaction and compliance with dietary recommendations.Diving into the complex transplant landscape, Dr. G candidly discusses the challenges faced by patients awaiting life-saving kidney transplants. He outlines DaVita's advocacy efforts to improve organ procurement policies and increase access to this critical treatment option through initiatives like the DaVita Transplant Community. By raising awareness and driving policy changes, DaVita aims to address the organ shortage crisis and provide more opportunities for patients to receive transplants.Furthermore, Dr. G recognizes the profound implications of an aging population on kidney health. DaVita's Kidney Smart℠ program focuses on early detection and preventive strategies, empowering individuals to take proactive steps toward maintaining optimal kidney function. Additionally, their specialized services like DaVita Assisted Living and DaVita Home Dialysis support the unique needs of elderly kidney patients, enabling them to receive high-quality care in familiar and comfortable settings. His passion for driving positive change and improving lives resonates throughout, inspiring hope and optimism for the future of nephrology at DaVita and beyond. With a steadfast commitment to innovation, compassion, and excellence, DaVita is poised to redefine the standards of kidney care, empowering patients to live their fullest lives.AboutDr. Giullian serves as the Chief Medical Officer of DaVita, a kidney care company dedicated to improving the holistic care and experience of patients suffering from kidney disease. Dr. G, as he is often referred to, received his MD from Vanderbilt University and his MBA from the University of Colorado at Denver. As CMO of DaVita, he is focused on transforming healthcare, reducing the global burden of kidney disease and restoring fulfillment for physicians caring for vulnerable patients.Dr. Giullian served on the board of directors for the Renal PhysiciSupport the show

In this episode, I talk to Dr. Nwando Anyaoku, a physician and public health advocate working tirelessly to address racial and socioeconomic disparities in healthcare.Dr. Anyaoku shares her personal story of growing up in Nigeria and witnessing firsthand the devastating impacts of inadequate access to quality healthcare. This experience inspired her to pursue a career in medicine to promote health equity.After completing her medical training in the United States, Dr. Anyaoku spent several years providing care in underserved communities. She quickly realized that while medical treatment is crucial, deeper systemic barriers are preventing many patients from achieving optimal health outcomes.Dr. Anyaoku emphasizes the importance of looking upstream to address the root causes of poor health. This means advocating for policies and interventions that target socioeconomic inequality, structural racism, environmental justice, and other societal factors influencing well-being.The episode explores some of Dr. Anyaoku's current initiatives, including:Working with community organizations to increase health literacy and patient advocacyResearching implicit biases in healthcare settingsDeveloping cultural competency training for medical professionalsLobbying for Medicaid expansion and affordable housing in underserved areasForging cross-sector partnerships to improve community health holisticallyThroughout the discussion, Dr. Anyaoku shares powerful stories that humanize the stark statistics around health inequities. Her passion for this work shines through as she calls for collective action to dismantle unfair systems and ensure everyone has a fair opportunity to thrive.AboutDr. Nwando Anyaoku is a physician executive, speaker, coach and consultant based in Seattle, Washington.A board-certified pediatrician, Dr Anyaoku serves as VP and Chief Health Equity officer for Providence Swedish Health Services. Working closely with clinical and community leaders, she leads efforts in advancing equity in healthcare and the delivery of culturally competent care, with an emphasis on technology and digital innovation. She is an experienced executive and physician leader with expertise in clinical and business decision making. Dr Anyaoku is faculty at Carnegie Mellon University Master of Medical Management program. As a strategic advisor and consultant, she not only specializes in health equity, but also provides leadership development and supports physicians and executives in every aspect of their leadership journeys, including career reimagining and strategic planning.Dr. Anyaoku is best known for her strong commitment to helping people and communities thrive and bloom where they are planted. When she’s not coaching and supporting medical leaders or speaking at conferences and special events, Dr Anyaoku serves as an active board member for several regional and national boards of directors. Dr. Anyaoku is a proud mother of two boys and an avid reader, traveler and cook.Support the show

In this episode, I am in conversation with Neuroscientist and "Godfather of VR" Dr. Walter Greenleaf. He shares his insights on the rapidly evolving roles of virtual reality (VR) and augmented reality (AR) in the healthcare sphere. Greenleaf, whose work explores the intersections of technology and human experience, discusses how immersive technologies like VR are being leveraged for medical training, therapy, and even surgical planning.The integration of augmented reality (AR) and virtual reality (VR) technologies within the healthcare ecosystem is no longer merely a novelty, but a clinically validated practice area. Among the many promising applications is the use of immersive solutions for mental health support and meditation enablement. For the veteran community grappling with the invisible wounds of post-traumatic stress disorder (PTSD), AR/VR is increasingly being explored as an adjunctive treatment option.At its core, VR exposure therapy recreates triggering environments and stimuli in a psychologically safe, controlled digital space. This controlled virtual exposure allows patients to gradually confront and process their traumatic memories and associations. Complementing this is the employment of AR for grounding and contextualized therapeutic interventions, superimposing calming visuals and psycho educational guidance onto real-world environments.Research indicates VR can enhance fear extinction and emotional processing for PTSD patients by integrating cognitive reappraisal with realistic multi-sensory experiences. For veterans, who may struggle to freely discuss their wartime ordeals, immersive environments facilitate perspective-taking and validation of subjective experiences. AR/VR interventions are also being studied for meditation facilitation by transporting users to simulated peaceful settings."What's most fascinating," Dr. Greenleaf noted, "is the potential for VR and AR to cultivate empathy and deeper understanding, not just technical proficiency." He drew parallels between the philosophy of mindful observation during meditation and the experiential nature of VR in healthcare contexts. Just as meditation encourages present, non-judgmental awareness, VR can allow medical professionals to step into the subjective experiences of patients and colleagues. By virtualizing different healthcare perspectives and realities," Greenleaf posited, we can develop a more holistic, empathetic appreciation for the full spectrum of experiences in the healthcare journey.AboutWalter Greenleaf, PhD, is a neuroscientist and medical technology developer. With over thirty years of research and development experience, Walter is considered a leading authority in digital medicine and medical Virtual Reality and Augmented Reality technology.Walter founded and served as CEO for Greenleaf Medical Systems, a medical product development company; InWorld Solutions, a company specializing in the therapeutic use of virtual worlds for behavioral health care; and Virtually Better, a company that develops virtual environments for the treatment of phobias, anxiety disorders, andPTSD. Walter was the founding Chief Science Officer for Pear Therapeutics, a pioneering company in SaMD. He served as Senior Vice President of Strategic & Corp. Affairs to MindMaze and is currently advising Interaxon as Chief Science Officer.Walter’s current research focus is on developing computer-supported clinical products, with a specific emphasis on applying virtual reality and digital health technology to address difficult problems in behavioral and physical medicine, such as Cognitive Aging, Post-traumatic stress, anxiety disorders, depression, traumatic brain injury andstroke, addictions, and autism spectrum disorder.His early research was on age-related changes in the Support the show

In this episode, I sit down with the Chief Medical Officer and SVP of R&D Life Sciences at PepsiCo to discuss the company's focus on improving the nutritional profile of its portfolio for the lives they touch every day. As a large global business, PepsiCo is acutely aware of the opportunity theyhave to offer positive choices for the individuals who enjoy their products. With rising rates of chronic conditions like diabetes and obesity, the CMO explains how PepsiCo is taking a proactive approach to nutrition. PepsiCo is making a concerted effort to provide more nutritious food and beverage options that still capture the cultural and regional flavors people love.We explore how PepsiCo is balancing consumer preferences with the need for healthier products. The CMO shares insights into PepsiCo's product innovation process and their focus on maintaining the taste and experience that individuals expect, while gradually improving the nutritional profile.This conversation underscores the role that large corporations can play in driving improvements to their suite of products to help improve public health. Companies like PepsiCo have a tremendous opportunity - and obligation - to positively impact the lives of millions around the world.PepsiCo is demonstrating how businesses can be a true force for good, advancing positive strategies and supporting communities globally.About:Dr. Tataranni is currently the Global Chief Medical Officer of PepsiCo. As Chief Medical Officer, Dr. Tataranni oversees all aspects of the company's efforts to protect its global workforce, products, and communities in the face of the COVID-19 pandemic and beyond. He also leads PepsiCo's Life Sciences strategy and the R&D Fellows Program as its Executive Sponsor. Dr. Tataranni joined PepsiCo in September, 2018 as the Senior Vice President of R&D Life Sciences, responsible for leading the development and execution of a nutrition and bio-sciences strategy in support of the company’s portfolio transformation and Pep+ agenda. Dr. Tataranni serves on the Boards ofseveral for-profit and non-profit organizations.Before joining PepsiCo, Dr. Tataranni was Senior Vice President, Head of Global Medical Affairs, Diabetes & Cardiovascular Business Unit, in charge of medical strategy worldwide and operations for mature markets at Sanofi. Previous responsibilities within the group included the roles of Vice President of Global Medical Affairs, Medical Director of Europe, Vice President for the Metabolism Medical Unit in the US affiliate (2006-2008), and Medical Director for the Metabolism Franchise. Between 1999 and 2004 he was Head of the Obesity, Diabetes and Energy Metabolism Unit at the Phoenix Epidemiology and Clinical Research Branch of the National Institutes of Health in the U.S. and Director of the Clinical Research Center at the same institution from 2000 through 2004. Support the show

In this inspiring episode, we're joined by  J. Nwando Olayiwola (Dr. O), MD, MPH, FAAFP, Senior Vice President and  She shares her powerful personal story of how her aspiration to work in healthcare began in childhood when she witnessed firsthand the profound impact physicians can have on people's lives. This experience sparked a passion that has driven her career journey to the highest levels of healthcare leadership.Dr. O discusses Humana's comprehensive approach to embedding equity into every aspect of the organization - from the boardroom strategy to the frontline delivery of care. A major focus is creating robust training programs around implicit bias, cultural competency, and how these factors influence care experiences and outcomes. She emphatically states that health equity is not just a dedicated team's responsibility but rather a core value that every Humana employee must embrace.We also explore how even at a hyper-local level, stark inequities can exist within communities just miles apart. Dr. O leaves us with three key takeaways for healthcare's future: 1) Practice equity locally but think globally, 2) Use data and technology as tools, not solutions, and3) Quality care and equity are inextricably linked.Support the show

In this compelling podcast episode, I sit down with Dr. Schlosser, the Senior Vice President of Care Transformation and Innovation at HCA Healthcare, to unravel the intricacies of clinically led transformation in healthcare. At the helm of the newly established department, Care Transformation & Innovation, within HCA Healthcare’s Clinical Operations Group, Dr. Schlosser spearheads a visionary initiative to reshape Models of Care in acute facilities. Focusing on a trifecta of digital enablement, patient-centered approaches, and heightened efficiency, he shares insights into the dynamic world of healthcare innovation. The episode explores the pivotal collaboration with HCA's Information Technology leadership for a robust Digital Transformation strategy and the groundbreaking partnership with Google's cloud computing team to improve data access, and patient experience and accelerate positive patient outcomes. Dr. Schlosser's leadership unfolds a narrative of leveraging data for transformative healthcare solutions, promising a future where patient care is not just redefined but elevated through cutting-edge technologies.About Dr Michael Schlosser, MBA, FAANS is Senior Vice President, Care Transformation and Innovation for HCA Healthcare. In this role, he leads clinical and operational innovation and transformation for the enterprise. He leads a new department whose purpose is to redesign care delivery within acute care facilities focusing on digitally enabled, patient-centred, and highly effective care delivery. This includes partnering with IT and cloud computing teams and providing leadership on the design and use of HCA’s Intelligence Net. These efforts will create real-time data and technology-enabled clinical operations. Dr Schlosser also oversees clinical informatics and the implementation of HCA’s next-generation EHR, Meditech Expanse.Before this role, he served as the Chief Medical Officer for the HCA National Group and as Vice President of Clinical Excellence and surgical services for HCA Clinical Services Group where he led the clinical operations for 105 acute care facilities across 14 States, overseeing quality, patient outcomes, clinical strategy, and innovation. He also served as the first CMO for HealthTrust, the exclusive GPO for more than 1600 hospitals across the US and HCA’s supply chain management organization.Dr Schlosser holds a bachelor’s degree in chemical engineering from Massachusetts Institute of Technology, a medical degree from the Yale School of Medicine, and an MBA from Vanderbilt Owen Graduate School of Management. He is a board-certified neurosurgeon and completed his residency and fellowship at Johns Hopkins. In clinical practice he focused on complex spine reconstruction. He has held multiple physician leadership roles while in clinical practice, including Chief of Surgery, Chief of Staff, and interim CMO of TriStar Centennial Medical Center in Nashville, Tennessee. He has also served as a medical officer in the USA's Food and Drug Administration’s Center for Devices and Radiologic Health.Support the show

Given the increasing burnout rate in the Healthcare industry and our desperate need to have great leaders in place, the art of cultivating resilience becomes key. In this episode, I am in conversation with renowned Suneel Gupta, a famous Author and Entrepreneur.Suneel Gupta shares his unique journey through a diverse career background, including law, an MBA, and involvement in healthcare innovation. His story involves entrepreneurial ventures, including working at Groupon and his many struggles in the journey of entrepreneurship. Suneel emphasizes the pivotal moments of failure and the lessons learned from setbacks, such as his experience as a speaker at the Failure Conference and the subsequent viral New York Times article featuring him as the "poster child for failure." He turned this vulnerability into an opportunity, reaching out to admired individuals for advice, leading to insightful conversations, and eventually shaping his current role as a global traveler, meeting top achievers, and exploring the habits that contribute to success.The conversation delves into the cultural perspective on failure, with Suneel acknowledging the challenges and shame associated with failure but highlighting the profound learning experiences and personal growth that arise from setbacks. He shares the concept of kintsugi, a Japanese art form symbolizing the beauty in repairing broken objects with golden lacquer, drawing parallels to embracing our vulnerabilities. The discussion transitions to resilience, with Suneel emphasizing the importance of daily moments in cultivating resilience. He introduces the Sanskrit concept of upeka, finding comfort in discomfort, and Viktor Frankl's idea of creating a space between irritation and response for true freedom. Suneel concludes by stressing the distinction between resilience and post-traumatic growth, advocating for the integration of reflective moments and self-love to facilitate genuine personal development.About As the founding CEO of RISE, a breakthrough wellness company, Suneel Gupta helped thousands of people build better habits for life and work. Now as a bestselling author and Harvard Medical School visiting scholar, Suneel has taken his mission one step further – helping people reset, reignite, and find meaning in their work by bolstering emotional resilience and engagement. Suneel asks, “How can an organization excel on the outside if its people are exhausted on the inside?” Grit and hustle are simply not a long-term answer to dealing with non-stop change and stress. Suneel offers leaders and teams a better way to work; one that results in sustainable innovation, productivity, and fulfillment. He arms people with science-based habits that will avoid burnout, boost energy, and improve their professional and personal lives.Suneel is a business survivor and the author of the international bestselling book Backable (2020). That book is rooted in his inner journey from a twice-failed entrepreneur to becoming a leader behind two IPOs and being named “The New Face of Innovation” by the New York Stock Exchange. The book reveals the mindset shifts and hidden habits of people who are extraordinary at pushing new ideas forward.In his transformative book, Everyday Dharma (2023) codifies Suneel’s mission to help people reset, reignite, and re-engage through a timeless practice called Dharma. Simply put, Dharma brings “who you are” and “what you do” into alignment. When we’re aligned, we can produce our best work and lead ourselves and others effectively, experiencing true joy along the way.As a visiting scholar at Harvard Medical School, Suneel researches and teaches the interconnection between inner well-being and outer leadership. He is also an emissary for Gross National Happiness between the United States and the Kingdom of Bhutan. Support the show

In this enlightening podcast episode, I sit down with Mike, a seasoned automotive executive and COO of Blink, bringing over 25 years of invaluable experience in the automotive and technology sectors. With a keen understanding of the industry, Mike is pivotal in overseeing Blink's sales, business development, and operational aspects, contributing significantly to the company's expansion in the U.S. and globally. The episode delves into the profound transformation in the automobile industry as it undergoes a drastic shift toward electric vehicles (EVs). Mike provides insights into the challenges and opportunities associated with this shift, emphasizing the importance of optimizing operations, manufacturing quality charging equipment, and delivering a superior customer experience.Beyond the automotive realm, the conversation expands to explore the interconnected relationship between the future of automobiles and public health. Mike discusses how the transition to EVs can contribute to a reduction in air pollution, positively impacting the well-being of communities and individuals. Furthermore, the episode touches upon the significance of LEED certification in healthcare systems, highlighting how environmentally sustainable practices, such as electric vehicle adoption, can contribute to earning ESG (Environmental, Social, and Governance) points. The discussion illuminates the potential benefits for patient care when healthcare facilities prioritize eco-friendly initiatives, promoting a healthier and more sustainable future.One can expect to gain valuable insights into the dynamic landscape of the automotive industry, the environmental implications of the EV revolution, and the integral role it plays in fostering public health. Mike's expertise provides a nuanced perspective on how businesses can align with broader sustainability goals, positively impacting both the automotive sector and the well-being of communities at large.About Mike is a seasoned automotive executive who brings over 25 years of automotive and technology experience to Blink with deep connections throughout the auto industry. As COO, Mike oversees Blink’s sales, business development, and all aspects of operations, playing a vital role in the Company’s expansion in the U.S. and globally. Mike is committed to optimizing Blink’s operations, producing quality charging equipment, and providing a best-in-class customer experience.Support the show

In this thought-provoking podcast episode, I engage in a heartfelt conversation with Piyush Tewari, a distinguished Indian social entrepreneur and the Founder and CEO of SaveLIFE Foundation. Focused on transforming road safety, enhancing access to emergency medical care, and championing urban governance in India, Tewari is best known for his instrumental role in advocating for the passage of the Good Samaritan Law in the country. The narrative unfolds as Tewari shares the profoundly personal origin of his mission—a poignant account of losing a cousin in a tragic accident. This catalyst ignited his unwavering commitment to reforming legislation in India.We are taken on a journey through Tewari's life, exploring the challenges and triumphs accompanying his pursuit to change the law and create a safer, more compassionate society. Notably recognized by GQ Magazine as one of the most influential young Indians and featured as an expert on the socially impactful TV show Satyamev Jayate, Tewari's story inspires those who seek to make a meaningful difference.This episode also delves into Tewari's broader vision beyond legislative changes, shedding light on the profound concept that healthcare extends far beyond the clinical setting. Through his experiences, we explore the interconnectedness of road safety, emergency medical care, and urban governance as integral components of a holistic approach to public health. Tewari's insights prompt reflection on the transformative power of social entrepreneurship and the potential for individuals to drive systemic change by addressing pressing societal issues.In essence, this podcast episode captures the essence of Piyush Tewari's impactful journey—from personal tragedy to becoming a catalyst for legal reform and social change in India. It not only highlights the transformative effects of one individual's dedication but also underscores the broader implications of healthcare as a multifaceted and interconnected aspect of societal well-being.AboutPiyush Tewari is an Indian social entrepreneur focused on improving road safety, access to emergency medical care, and urban governance across India. He is the Founder and CEO of SaveLIFE Foundation, and is best known for his work to pass a Good Samaritan Law in India. In 2016, GQ Magazine named him one of the most influential young Indians. In 2014, Tewari was featured as an expert on Satyamev Jayate, a popular TV show on social issues hosted by actor Aamir Khan. The episode Tewari was featured in was focused on the epidemic of road accidents in India.He is also an empaneled speaker with The Outstanding Speakers Bureau and is the subject of "The Golden Hour", a feature documentary produced by Roma Sur and Jessica McGough of the Film School at the University of Colorado, Denver, USA. He is a commentator on Road Safety in Indian media and has been covered by the New York Times, TIME Magazine, and National Geographic, among other media outlets.Support the show

In a captivating dialogue with Shyamal Patel, Head of Science at Oura Ring, we embarked on a journey into the heart of the science of sleep and its profound implications for healthcare and wellness. With infectious enthusiasm, Patel narrated how the Oura Ring is not just a wearable but a beacon illuminating the path to optimal health through a deep understanding of sleep patterns. The interview was a testament to sleep's pivotal role in overall well-being, emphasizing the importance of leveraging data to tailor personalized wellness strategies. With its intricate sensors and algorithms, Patel's insights underscored how the Oura Ring is a guardian of restorative sleep, offering a tangible tool for individuals and healthcare professionals to enhance the quality of life through proactive wellness management.In an unexpected and groundbreaking turn, Patel delved into the intersection of the Oura Ring with fertility tracking. This revelation added a new chapter to the narrative, where technology meets the delicate nuances of reproductive health. The Oura Ring's integration of fertility insights brings a holistic dimension to healthcare, providing individuals with a comprehensive view of their well-being.  Their recent partnership with Headspace, which drives to focus on one's mental health and clubbing their presence in the FSA/HSA segment, ensures the affordability and availability of Oura ring was refreshing.This innovation aligns with the evolving landscape of personalized medicine. It positions the Oura Ring as a trailblazer in merging cutting-edge technology with the delicate intricacies of individual health journeys.AboutShyamal Patel is the Head of Science at ŌURA, where he leads an interdisciplinary organization focused on research and development of algorithms that translate sensor data into accurate measures of health and wellbeing. He is passionate about building digital health solutions that transform healthcare from a largely subjective, episodic, and reactive model to become more objective, continuous, and proactive. Before ŌURA, Shyamal led data science teams in several startups and, most recently, at Pfizer, where his work was focused on the development, validation, and deployment of new digital endpoints across multiple therapeutic areas in regulated clinical trials. Shyamal has a PhD in electrical engineering specializing in signal processing and applied machine learning from Northeastern University. He completed his post-doctoral research at Harvard University and lives in Boston.Support the show

In this compelling podcast episode, I engage in a profound conversation with Jared Genser, renowned as "The Extractor" by The New York Times, acknowledging his tireless efforts in liberating political prisoners globally. Serving as pro bono counsel to five Nobel Peace Prize Laureates, Genser's impact is highlighted by his representation of figures like Aung San Suu Kyi, Liu Xiaobo, and Ales Bialiatski—individuals whose laurels were earned while enduring imprisonment. The discussion navigates through the intricacies of Genser's journey, unraveling his unwavering dedication, resilience, and profound belief in the inherent right to freedom.As we explore the profound stories behind Aung San Suu Kyi, Liu Xiaobo, and Ales Bialiatski, imprisoned laureates whom Genser has championed, the podcast delves into the intersectionality of human rights and the pressing need for justice on a global scale. Genser's commitment to serving as the legal voice for those who have been silenced sheds light on the challenges inherent in navigating complex legal landscapes while advocating for fundamental rights.Genser's narrative unfolds as a testament to the delicate balance required when fighting for the rights of others, emphasizing the need to align legal strategies with a moral compass.In essence, this podcast episode serves as a powerful exploration of Jared Genser's life and work, offering a profound understanding of the challenges and triumphs that come with being at the forefront of human rights advocacy. It inspires reflection on the shared values of dedication, resilience, and the pursuit of freedom, both in the legal arena and in the broader context of conducting business with dignity.AboutJared Genser has been an international human rights lawyer for over two decades. He is Managing Director of Perseus Strategies, a public interest law firm, Special Advisor on the Responsibility to Protect to the Organization of American States, and outside General Counsel to the Neurorights Foundation. Referred to by the New York Times as “The Extractor” for his work freeing political prisoners worldwide, he has served as pro bono counsel to five Nobel Peace Prize Laureates, including the last three Laureates who won their Prize while imprisoned — Aung San Suu Kyi (Burma, 2006-2010), Liu Xiaobo (China, 2010-2017), and Ales Bialiatski (Belarus, 2023-Present) — as well as Archbishop Desmond Tutu and Elie Wiesel.Genser was previously a partner in the government affairs practice of DLA Piper LLP and a management consultant with McKinsey & Company. He has also been an Adjunct Professor of Law at Georgetown University Law Center, the University of Pennsylvania Law School, and the University of Michigan Law School, across which he taught semester-long seminars about the UN Security Council seven times.In addition, he was an Associate of the Carr Center for Human Rights Policy at Harvard University from 2014-2016, a Visiting Fellow with the National Endowment for Democracy from 2006-2007, and earlier in his career was named by the National Law Journal as one of “40 Under 40: Washington’s Rising Stars.” Genser’s other past clients have included former Czech Republic President Václav Havel, Malaysian Prime Minister Anwar Ibrahim, and former Maldives President Mohamed Nasheed. Over his career, he has also advised multilateral institutions, governments, companies, foundations, and civil society organizations on ensuring their work was consistent with international human rights, labor rights, and environmental rights standards. Coming from his experience freeing his first client as a law student, in 2001 he founded Freedom NowSupport the show

In this enlightening podcast interview with Dr. Momo, Chief Science Officer at Viome, we delve into the profound significance of microbiome research and its pivotal role in maintaining optimal health. With meticulous research and compassionate insight, Dr. Momo elucidates how the intricate ecosystem of microbes living within us profoundly influences our mental and physical well-being.Drawing on a wealth of scientific studies, Dr. Momo highlights the symbiotic relationship between the human body and its microbial inhabitants. These tiny organisms, residing in our gut, skin, and other organs, play a monumental role in digestion and immune response functions. Their delicate balance is a linchpin of overall health.He underscores the connection between gut health and mental well-being through empathetic storytelling. As research advances, we are beginning to fathom the extent to which the microbiome shapes our emotional states. A flourishing microbial community is intrinsically linked to reduced anxiety, improved mood, and enhanced cognitive function. Dr. Momo provides touching anecdotes and relatable scenarios that underscore the profound impact of microbiome health on individual lives.Furthermore, the conversation delves into the vital importance of personalized nutrition. Dr. Momo vividly describes how understanding one's unique microbial composition can revolutionize dietary choices. By tailoring nutrition plans to support the specific needs of an individual's microbiome, we can unlock a new level of vitality and well-being.The podcast also delves into the implications of an imbalanced microbiome on chronic diseases and conditions. Dr. Momo shares poignant stories of patients who have experienced transformative recoveries through microbiome-focused interventions, illuminating the hope and potential this research brings to those suffering from various health challenges.As the conversation draws to a close, he leaves us with a resonant message: the microbiome is not only a subject of scientific curiosity but a cornerstone of our health and vitality. We collectively agree that we must approach our well-being with reverence and curiosity, recognizing the profound impact that nurturing our microbiome can have on our mental and physical health.AboutMomo is an entrepreneur-scientist whose passion is to advance scientific discoveries into tools that improve humanity. He is focused on building a healthier future without pandemics, chronic diseases, and cancer. He has used his extensive scientific expertise and business acumen to lead the development of advanced technologies and their application towards healthier humanity. These technologies are enabling the transformation of the current healthcare, which focuses on symptom management, into a completely novel preventative and curative model, where individuals can take control of their health and maintain a long health span.Before co-founding Viome in 2016, Momo spent 12 years at Los Alamos National Laboratory, leading the Applied Genomics team.Momo obtained his Ph.D. in Chemistry from the University of Utah and BS in Microbiology from the University of Texas at El Paso. He is also an adjunct professor at New Mexico Tech University.Support the show

" The love for all living creatures is the most noble attribute of man" - Charles Darwin I am in conversation with James Wilks, producer of the groundbreaking documentary "The Game Changers," which sheds light on the transformative power of a plant-based diet for athletes and emphasizes its pivotal role in shaping the future of health and nutrition.Wilks highlighted the documentary's core message: that a plant-based diet can not only meet but exceed the nutritional needs of high-performance athletes. He cited numerous examples of elite athletes featured in the film who have successfully transitioned to a plant-based lifestyle, dispelling myths surrounding the perceived necessity of animal products for peak athletic performance.The conversation delved into the substantial research underpinning the documentary's claims. Wilks emphasized that a plant-based diet can provide athletes ample protein, essential amino acids, and a rich array of vitamins and minerals. He discussed studies revealing how plant-based diets can enhance cardiovascular health, accelerate recovery, and reduce inflammation, ultimately contributing to prolonged athletic careers.Moreover, Wilks elucidated the environmental and ethical implications of adopting a plant-based lifestyle. He highlighted how plant-based diets contribute to sustainability and mitigate the environmental impact of animal agriculture, a message resonating with a growing global audience.Wilks also emphasized the importance of dispelling common misconceptions about plant-based nutrition. He addressed concerns about potential nutrient deficiencies, underscoring the need for a balanced and well-planned diet incorporating various plant-based foods.He launched his new product FYTA- A Plant-based protein powderusing CODE: HLTH10 for a discount. https://www.fyta.com?rstr=HLTH10     The interview concluded with a forward-looking perspective on the future of health and nutrition. Wilks underscored the role of education in empowering individuals to make informed dietary choices. He expressed optimism that a shift towards plant-based nutrition will not only benefit athletes but also have a positive impact on overall public health.AboutJames Wilks is a film producer, vegan activist, and former professional mixed martial artist. He is best known for directing and starring in The Game Changers. The documentary is one of Netflix’s most popular shows. According to Google trends, interest in plant-based diets tripled within a week of it hitting the site.As an MMA fighter, James made his professional debut in the UFC in 2009 and was crowned welterweight champion. Extensive injuries eventually caught up with him, and he retired from professional MMA in 2012.Setting off on a path of physical recovery, James researched how diet might help him train faster and better. He came across a study on the original Roman gladiators and found their diets were predominantly vegetarian. This sparked his decision to follow a plant based diet himself.The Game Changers followed James through his recovery and adoption of a vegan diet. James experienced huge benefits, including increased physical stamina and improved health markers. In the documentary, James discussed his findings with other elite athletes who follow plant-based diets, including Arnold Schwarzenegger, Lewis Hamilton, and Dotsie Bausch. The show also looked at the potential environmental benefits of decreased meat consumption.Support the show

In a deeply insightful conversation with Dr. Asima Ahmad, the visionary founder of Carrot Fertility, we explored the nuanced landscape of fertility rates in the US, the imperative role of companies in empowering women with fertility choices, the emerging discourse around menopause normalization, and the evolving trend of delayed motherhood, coupled with the cost intricacies of egg freezing.With a compassionate and intellectual demeanor, Asima Ahmad illuminated contemporary women's pressing fertility challenges. Fertility rates in the US have been experiencing a steady decline, a complex interplay of societal, economic, and personal factors. These factors have led to women opting for motherhood at a later stage, thereby underscoring the need for innovative fertility solutions.Asima fervently advocated for companies to recognize the significance of providing fertility options to women. She emphasized that when organizations extend support for fertility treatments, they honor the diverse trajectories of women's lives and contribute to a more inclusive and empathetic workplace. This symbiotic relationship between employers and employees, where choices align with aspirations, is at the core of Carrot Fertility's mission.One remarkable aspect of our conversation was the emphasis on normalizing menopause—an often overlooked phase in a woman's life. By shedding light on this transitional period and encouraging open conversations, we can challenge stigmas and ensure that women move through this life stage with dignity, awareness, and support.Regarding the trend of women opting for motherhood at a later age, Asima delved into the complexity of modern life dynamics. Factors such as education, career aspirations, and financial stability have influenced women's decisions to delay having children. She gracefully underscored the importance of a society that respects and supports individual choices, allowing women to define their own timelines.The conversation also delved into the financial dimension of fertility preservation, particularly egg freezing. Asima navigated the delicate balance between hope and practicality, acknowledging the significant investment involved in these procedures. She highlighted how Carrot Fertility endeavors to ease this burden through partnerships with companies, making the process more accessible and equitable.In the tapestry of our discussion, Asima Ahmad's voice emerged as a beacon of empathy, insight, and empowerment. Her pioneering work at Carrot Fertility addresses the essence of fertility and weaves together the threads of societal evolution, personal agency, and the genuine pursuit of holistic well-being. Through her initiatives, she navigates the delicate realms of fertility with wisdom, compassion, and a profound dedication to shaping a world where women's choices are truly celebrated.About:Asima Ahmad, MD, MPH, FACOG, is co-founder and Chief Medical Officer (CMO) of Carrot Fertility, the leading global fertility care platform for women, plus people of every age, race, income, sex, sexual orientation, gender, marital status, and geography. As Carrot’s CMO, Dr. Ahmad leads clinical strategy, overseeing the company’s expansive network and telehealth program, which offers access to more than 10,000 reproductive endocrinologists, urologists, adoption experts, mental health experts, OB/GYNs, doulas, and midwives. Support the show

In an era where mental health concerns have taken center stage, organizations like The Jed Foundation have been instrumental in generating awareness and support for young individuals struggling with mental health issues. In an exclusive interview, I had the privilege of speaking with John MacPhee, CEO of JED , to gain insights into their efforts to address mental health challenges among teens in the United States.Adolescents in the US are grappling with prevalent mental health issues such as depression, anxiety, and stress, exacerbated by factors like academic pressure, social media, and the aftermath of the COVID-19 pandemic. JED  plays a pivotal role in addressing these challenges by collaborating with educational institutions to provide comprehensive, evidence-based resources that promote emotional health.Through a multifaceted approach, the foundation engages and educates teenagers by leveraging social media platforms to share relatable content, personal stories, coping strategies, and resource information. They also conduct interactive events and workshops in schools and colleges, fostering open dialogues about mental health and reducing stigma.Central to the foundation's mission is suicide prevention. They work diligently to build a community that recognizes signs of emotional distress and equips educators, parents, and peers with intervention skills. JED promotes holistic well-being, emphasizing healthy coping mechanisms and resilience-building activities to mitigate the risk of suicide.The COVID-19 pandemic prompted the foundation to swiftly adapt their strategies to virtual platforms, ensuring that support remained accessible. By doing so, they underscored the urgency of their work in a time of heightened anxiety and isolation.Looking ahead, JED aspires to expand their reach and collaborate with more educational institutions, aiming to normalize mental health education in schools. Their ultimate goal is to create a society where seeking help is seen as a sign of strength and where no teenager feels alone in their struggles. Through their unwavering commitment,  JED  is not only creating awareness about teen mental health but also playing a pivotal role in preventing suicide and shaping a more compassionate future.AboutJohn brings 25 years of leadership and management experience from the business and not-for-profit settings to his role at The Jed Foundation. Passionate about supporting young adults in their transition to adulthood, John advises several organizations including the S. Jay Levy Fellowship for Future Leaders at City College, Trek Medics, Crisis Text Line, the Health Policy and Management Department at the Mailman School of Public Health, and HIV Hero.Earlier in his career, he served in executive positions for Par Pharmaceutical, Inc. and Forest Laboratories, where he oversaw functions such as business development, alliance management, clinical development, regulatory affairs, sales and marketing. John continues to contribute to the development of novel medications for disorders such as Parkinson’s disease through board roles with Adams Pharmaceuticals and Blackthorn Therapeutics.In 2016, John received The Allan Rosenfield Alumni Award for Excellence in the field of public health from the Joseph L. Mailman School of Public Health at Columbia University. He earned a BA from Columbia College, an MBA from New York University and an MPH from Columbia University. Support the show